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Abstract:
In eukaryotic cells, proteins traversing the secretory pathway are
transported from the endoplasmic reticulum (ER) to the Golgi apparatus by
membrane-bounded vesicles formed by the recruitment and assembly of
cytosolic coat components upon the ER membrane. Three cytosolic factors,
collectively termed COPII, have been shown to be required for vesicle formation
in the yeast S. cerevisiae: the Sec23p/Sec24p protein complex, the
Secl3p/Sec31p protein complex, and the small GTP-binding protein Sarilp.
Recent evidence suggests that the membrane-associated protein Secl 6p also
participates in the formation of the vesicle coat, and may be considered an
additional component of the COPII complex.
To better understand the role of COPII subunits, we have adopted two
different approaches:
1. Identification of yeast proteins that are associated with COPII subunits.
We have found that Sec31p binds not only Secl3p, but also Secl6p, Sec23p,
and Sec24p. A different region of Sec31 p appears to mediate each of these
interactions. In addition, we have shown that the binding of Sec31 p to Secl 6p
is necessary for ER to Golgi transport. We propose that Secl6p organizes the
assembly of a coat which is stabilized both by the interaction of Sec3l p with
Sec23p and Sec24p, as well as by the interaction of all three of these
components with Secl6p.
2. Identification and characterization of COPII homologs in mammalian
cells. We have shown that although the mammalian homolog of SEC13,
Sec 13R, does not complement a secl3-1 mutant, chimeric constructs
representing the N-terminal half of either Secl3p or Secl3Rp, and the C-
terminal half of the other protein, are able to complement the sec13-1 secretion
defect. We have also demonstrated that in mammalian cells, Sec13Rp is
localized to the cisternae and vesicles in the region of the transitional ER. In
addition, we have shown that yeast Secl3p and human Sec13Rp both interact
with the same region of yeast Sec31 p. Collectively, these results suggest that
the function of Secl3p -- and of the COPII coat as a whole -- has been
evolutionarily conserved.
Thesis Supervisor: Chris A. Kaiser
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Chapter I
COPII coat proteins: mediators of vesicle formation
and cargo selection at the endoplasmic reticulum
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PREFACE
Portions of this chapter are in press in "The Molecular and Cellular
Biology of the Yeast Saccharomyces." Vol. 3. Broach, J.R., Pringle, J., and E.
Jones, Eds. Cold Spring Harbor Laboratory Press, as:
Chris A. Kaiser, Ruth E. Gimeno, and David A. Shaywitz. Protein Secretion,
Membrane Biogenesis, and Endocytosis. Pp. 1 - 137.
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Overview
A defining characteristic of eukaryotic cells is the presence of organelles
-- distinct, membrane-enclosed compartments evolved to host a specific set of
biochemical reactions. The ability to create enclosed intracellular spaces
presumably affords the eukaryotic cell greater opportunity to utilize processes
that would be difficult to carry out in a less specialized biochemical
environment. Thus, while proteins synthesized by bacteria are compelled to
mature under essentially identical conditions -- the chemical environment of
the bacterial cytoplasm - proteins synthesized by eukaryotic cells are afforded
two potential pathways: they can either fold in the cytoplasm or enter the
specialized organelles comprising the secretory pathway. These organelles --
and the mechanism of transport between them -- will be the focus of this
discussion.
Almost every eukaryotic protein destined either for release into the
extracellular space or for residence in the plasma membrane or the lysosome
(vacuole in yeast) travels through a defined series of organelles, starting with
the endoplasmic reticulum (ER), and continuing through the cis-, medial-,
and trans-Golgi. Travel from one compartment to another is mediated by
membrane-bounded vesicles which bud from the donor compartment and
later fuse with the target organelle (Palade, 1975). In the most fully
understood examples of protein transport between organelles, vesicle
budding is accompanied by the assembly upon the membrane of a coat that is
derived from soluble cytosolic proteins. The coat is thought to contribute to
both the formation of the vesicle and the selection of its cargo; this dual role
is particularly important because it implies that coat proteins are information-
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rich. Consequently, the study of coat proteins is likely to yield important
insights into both the biomechanics of vesicle formation as well as the
regulation of cargo transport.
Three different types of coated vesicles have been well-characterized in
yeast and mammalian cells. The first class of coated vesicles to be discovered
has a cytosolic coat composed of an outer lattice of clathrin and four
additional proteins that constitute the adaptor protein (AP) complex (Pearse
and Robinson, 1990). Clathrin-coated vesicles in mammalian cells are
responsible for transport steps directed to the lysosome either from the
plasma membrane or from the trans-Golgi compartment. A second type of
vesicle coat, known as COPI, was discovered by cell-free reconstitution of
transport between Golgi compartments. These vesicles are coated with a
complex of seven proteins known as coatomer (Rothman 1994). The
involvement of COPI vesicles in transport through the Golgi has yet to be
established definitively in vivo. Experiments in yeast have shown that COPI
vesicles are involved in retrograde transport from the Golgi to ER
(Letourneur et al., 1994) and in budding from the ER (Bednarek et al, 1995).
The third vesicle type carries proteins from the ER to the Golgi and is coated
with a set of proteins known as COPII (Barlowe et al., 1994).
ER to Golgi Transport I: Role of the ER
The ER is the first compartment of the secretory pathway, and
facilitates at least three processes critical for secretion: (1) folding of secretory
proteins; (2) oligmerization of secretory proteins; (3) initial glycosylation of
secretory proteins. Secretory proteins entering the ER encounter an
environment very different than that of the cytosol; perhaps most
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significantly, the ER is an oxidizing environment and facilitates the
formation of disulfide bonds, while the cytoplasm is a reducing environment,
and is not conducive to disulfide bond formation. The folding of secretory
proteins in the ER is also facilitated by a number of resident ER proteins,
including protein disulfide isomerase, which is thought to mediate disulfide
bond rearrangement, and BiP, which appears to stabilize partially-folded
intermediates (Freedman, 1984; Bole et al., 1986).
The oligomerization of many protein complexes also occurs in the ER;
examples include the viral hemagglutinin trimer, the yeast V-ATPase protein
complex, and the mammalian T-cell receptor complex (Doms et al., 1993;
Bauerle et al., 1993; Bonifacino et al., 1989). Many proteins also receive
glycolytic modifications en route through the secretory pathway,
modifications which are usually initiated in the ER. Glycosylation has been
shown to be important for intracellular protein folding and targeting, as well
as for the stabilization of secreted proteins in the extracellular environment
(Gahmberg and Tolvanen, 1996).
Following proper folding, oligomerization (if appropriate), and initial
glycosylation in the ER, secretory proteins are transported to the cis-Golgi via
membrane-enclosed vesicles, approximately 60 nm in diameter. Considerable
evidence has accumulated indicating that the entry of cargo molecules into
ER-derived secretory vesicles reflects an important sorting decision made by
the cell. For example, although discrete retention signals (which allow
resident ER proteins to be retrieved from the Golgi) have been characterized
(Pelham, 1995), resident ER proteins lacking these signals still exit the ER at a
rate much slower than that of actual secreted proteins (Munro and Pelham,
1987; Hardwick et al., 1990). Furthermore, careful immuno-electron
microscopy (EM) studies suggest that in mammalian cells, at least some
-10-
secretory proteins are concentrated during ER to Golgi transport (Mizuno and
Singer, 1993; Balch et al., 1994). Finally, COPII vesicles formed in vitro from
either microsomes or from nuclear envelope preparations are enriched for
proteins known to enter the secretory pathway, and seem to lack resident ER
proteins (Barlowe et al., 1994; Bednarek et al., 1995). These data suggest that a
distinction between resident and transported protein is made in the ER, at the
level of packaging into transport vesicles.
ER to Golgi Transport II: Experimental approaches
The dissection of ER to Golgi transport in yeast has been facilitated by
both the discovery of conditional mutants that are defective in either vesicle
formation or vesicle fusion, and by in vitro reconstitution studies which
have helped to define the essential components of the assembly and fusion
machinery.
The first genetic screen for secretory (sec) mutants identified twenty-
three complementation groups; analysis of the maturation of a marker
protein revealed that a subset of the sec mutants were defective in ER to Golgi
transport (Novick et al., 1981). Careful morphological analysis further
divided the ER to Golgi transport-defective mutants into a class required for
the formation of vesicles and a class required for the consumption of vesicles;
vesicle consumption mutants (including secl7, sec18, and sec22) accumulated
50nm transport vesicles, while vesicle formation mutants (including secl2,
secl3, secl6, and sec23) did not (Kaiser and Schekman, 1990). Epistasis analysis
confirmed that vesicle formation mutants function at an earlier stage than
vesicle consumption mutants (Kaiser and Schekman, 1990).
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The second approach to dissection of ER to Golgi transport is based on
the in vitro reconstitution of this transport step (Baker et al., 1988; Ruohola et
al., 1988). In its simplest form, in vitro ER to Golgi transport assays measure
addition of Golgi-specific carbohydrate modifications to radiolabeled prepro-
a-factor that has been post-translationally translocated into the ER. Gently-
lysed cells or partially purified ER membranes can serve as a donor
compartment, while the acceptor compartment is generally supplied by a
membrane fraction enriched in Golgi membrane by differential
centrifugation. In the presence of exogenously added cytosolic proteins and
ATP, typically 25 to 50% of the input a-factor is modified in this system.
The basic in vitro assay has been modified to allow vesicle formation to
be evaluated independently of vesicle fusion. The assay for vesicle budding
begins with a-factor within rapidly sedimenting ER membranes, and follows
its conversion to a slowly sedimenting fraction that corresponds to free
vesicles (Groesch et al., 1990; Rexach et al., 1991; Rexach et al., 1994; Barlowe et
al., 1994; Oka and Nakano, 1994). In this assay, mutants required for vesicle
formation in vivo (such as secl2 and sec23 ) were also found to be defective
for vesicle budding in vitro. Similarly, the vesicle accumulating mutant
secl8 was shown to be defective for vesicle fusion in vitro (Rexach et al., 1991;
Rexach et al., 1994; Oka and Nakano, 1994). Importantly, these studies of
mutants establish a faithful correspondence between the in vitro transport
assay and the events that occur in vivo.
Attempts to purify ER to Golgi transport vesicles from whole cells have
failed probably because of the low abundance of these organelles. Pure ER to
Golgi transport vesicles can be produced in quantity by in vitro budding
reactions under conditions where vesicle fusion with an acceptor
compartment is inhibited by mutation, antibody, or the absence of fusion
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factors (Groesch et al., 1990; Rexach et al., 1994; Barlowe et al., 1994; Oka and
Nakano, 1994). Purified ER-derived vesicles thus produced are functional
transport intermediates since they are competent to fuse with Golgi
membranes (Groesch et al., 1990; Rexach et al., 1994; Barlowe et al., 1994; Oka
and Nakano, 1994). ER-derived vesicles produced in vitro have uniform
morphology (-60 nm diameter), and when formed under the appropriate
conditions are encapsulated in a protein coat that can be visualized by
electron microscopy after fixation and staining with tannic acid. This coat
consists of a subset of the proteins required for vesicle formation in vivo and
in vitro, and has been termed COPII (Barlowe et al., 1994). Vesicle production
in vitro appears to reproduce the normal selectivity in segregation of vesicle
proteins from ER proteins that occurs before or during vesicle formation,
since the vesicles that bud in vitro contain known vesicle docking factors,
such as Sec22, and Bos1p, but do not contain resident ER proteins (Barlowe et
al., 1994; Rexach et al., 1994; Lian and Ferro-Novick, 1993). In addition, these
vesicles have a characteristic set of twelve membrane proteins, termed ERV
(ER-vesicle associated) proteins, one of which has been shown to be
Emp24p/Bst2p (Rexach et al., 1994; Schimm611er et al., 1995).
ER to Golgi Transport III: COPII coat components
A. Overview
Vesicle formation from the ER in vitro requires both ER membranes
and concentrated cytosolic protein. Five polypeptides - two heteromeric
protein complexes, the Sec23p/Sec24p complex and the Secl3p/Sec31p
complex, and a small GTP-binding protein, Sarlp - in pure form will satisfy
this requirement for cytosolic protein in vesicle budding (Salama et al., 1993;
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Barlowe et al., 1994). These five proteins are present on completed vesicles
and are abundant components of the COPII coat (Barlowe et al., 1994). The
COPII coat is morphologically distinct from the clathrin coat, and does not
contain components of the coatomer (COPI) coats (Barlowe et al., 1994;
Bednarek et al., 1994). In addition to these cytosolic factors, two additional
proteins -- Secl6p and Secl2p -- are also involved in COPII vesicle formation.
Secl6p is a protein that is tightly associated with the ER membrane and is also
present on ER-derived vesicles produced in vitro (Espenshade et al., 1995).
Secl6p binds to three cytosolic COPII coat components, Sec23p, Sec24p and
Sec31p, and may be a foundation upon which these proteins assemble
(Espenshade et al., 1995; Gimeno et al., 1996; Shaywitz et al., 1997). The
integral ER membrane proteins Secl2p may regulate COPII vesicle formation,
but is not incorporated into completed vesicles (Barlowe et al., 1994; Gimeno
et al., 1995).
It is important to note that the distinction between cytosolic and
membrane-associated COPII coat components is defined by the behavior of
the in vitro assay as carried out on ER membranes that have been extracted
with urea to remove peripheral proteins, and may not accurately reflect the
distribution of these proteins in living cells. For example, Sec23p and Sarlp
have been defined as cytosolic COPII coat components in the context of the in
vitro assay, yet depending upon the lysis conditions, these proteins can also be
found associated with membranes in crude cell extracts. It is also noteworthy
that the in vitro budding assay has been most useful for study of essential
factors that can be depleted from the starting ER membranes and then be
added back in soluble form. Additional peripheral membrane proteins like
Secl6p that are not easily extracted from ER membranes may have initially
escaped detection by the budding assay.
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B. Sec23p/Sec24p
SEC23 was initially isolated as an ER to Golgi mutant in the original sec
screen, and was subsequently determined to participate in vesicle formation
(Novick et al., 1981; Kaiser and Schekman, 1990). The conservation of the
temperature sensitive phenotype under in vitro conditions facilitated the
biochemical isolation of Sec23p activity from wild-type cytosol (Baker et al.,
1988; Hicke et al., 1989). Functional Sec23p was purified as a 300-400 kD
complex that contains both the 85 kD Sec23p and a 105 kD protein designated
Sec24p (Hicke et al., 1992; Yoshihisa et al., 1993); the precise stoichiometry of
these two protein partners has not yet been established. Sec24p, like Sec23p, is
essential, and is required for ER to Golgi transport both in vitro (Barlowe et
al., 1994) and in vivo (R. Gimeno, A. Frand, and C. Kaiser, unpublished
observations). Furthermore, the Sec23p/Sec24p complex represents one of
the major components of the COPII vesicle coat, and is required for its
formation (Barlowe et al., 1995; Bednarek et al., 1995).
Not only do Sec23p and Sec24p interact with each other, both
biochemically and genetically, but they also each exhibit genetic interactions
with the genes encoding the other COPII components -- SEC13, SEC31, SEC16,
and SAR1. Secl6p has been shown to bind directly to both Sec23p and Sec24p;
the two protein partners bind to different sites on Secl6p, and the binding of
one subunit can occur in the absence of the other (Gimeno et al., 1996).
Sec31p also has been shown to bind directly to both Sec23p and Sec24p; for
these interactions as well, the binding of one subunit to Sec31p does not
require the presence of the other (Shaywitz et al., 1997). Sec23p has also been
shown to function as a GTPase-activating protein (GAP) for Sarlp,
stimulating its GTPase activity by a factor of ten; Sec24p does not appear to
-15-
affect the GAP activity of Sec23p (Yoshihisa et al., 1993). While the GAP
activity of Sec23p has also stimulated the generation of several different
hypothesis regarding Sec23p function (Oka and Nakano, 1994; Schekman and
Orci, 1996), the role of the Sec23p/Sec24p complex in the formation of COPII
vesicles still remains to be established.
Two human Sec23 homologs have been identified, hSec23Ap and
hSec23Bp (Paccaud et al., 1996). The hSec23A protein complements a yeast
sec23 temperature sensitive mutant, and in mammalian cells, has been
localized to the cisternae and vesicles in the region of the transitional ER. Gel
filtration analysis of HepG2 cytosol suggests that hSec23Ap (like yeast Sec23p)
fractionates as a 350 kD complex. Immunoprecipitation of hSec23A from
clarified cytosol identifies a prominent band with an apparent molecular
weight of 110 kD; this is approximately the molecular weight of yeast Sec24p.
Although a mammalian Sec24p homolog has not yet been cloned, a cDNA
encoding a protein with significant homolog to Sec24p has been reported
(D38555; KIAA0079 gene product; Nomura et al., 1994).
C. Secl3p /Sec31p
SEC13 was isolated in the original screen for secretion mutants and was
shown to be required for the vesicle formation step of ER to Golgi transport
(Novick et al., 1981; Kaiser and Schekman, 1990). Immunodepletion
experiments revealed a requirement for Secl3p in the in vitro transport assay
(Pryer et al., 1993; Salama et al, 1993). Purification of Secl3p activity from
wild-type cytosol revealed that Secl3p exists as a complex with the 150 kD
Sec31p protein (Pryer et al., 1993; Salama et al, 1993; Salama et al., 1997).
Although the size of the Sec31p/Secl3p complex was initially estimated to be
approximately 700 kD, based on gel-filtration chromatography (Salama et al.,
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1993), more recent studies using sedimentation through a glycerol gradient
resulted in a size determination of 166 kD, approximately the predicted size of
a Secl3p/Sec31p dimer (Salama et al., 1997). Both SEC13 and SEC31 are
essential genes, required for vesicle transport in vivo and in vitro (Kaiser and
Schekman, 1990; Salama et al., 1993; Barlowe et al, 1994; Wuestehube et al.,
1996). The Secl3p/Sec31p complex, like the Sec23p/Sec24p complex,
represents a major component of the COPII coat and is required for its
formation (Barlowe et al., 1994; Bednarek et al, 1995).
Both SEC13 and SEC31 exhibit genetic interactions with the other COPII
genes (SEC23, SEC24, SAR1, SEC16) (Kaiser and Schekman, 1990; Gimeno et
al, 1995; Salama et al., 1997; A. Frand and C. Kaiser, unpublished
observations). Structurally, Secl3p appears to consist almost entirely of six
WD-40 repeats, a motif first described in the 3-subunit of trimeric G-proteins,
and subsequently shown to specify a P-propeller structure (Neer and Smith,
1996). Secl3p interacts with a WD-40-containing domain of Sec31p, raising
the possibility of a homotypic interaction (Shaywitz et al., 1997). Secl3p also
appears to interact with Secl6p (Appendix II), consistent with the proposed
role for Secl6p in organizing COPII coat assembly (vide infra).
Further analysis of Sec31p has demonstrated that in addition to binding
Secl3p, it can also bind Sec23p, Sec24p, and Secl6p (Shaywitz et al., 1997).
While the N-terminal (WD-40) region of Sec31p appears to mediate binding
to Secl3p, the extreme C-terminal region is required for binding to Secl6p. A
Sec31p mutant lacking the final 127 amino acids of the 1273-amino acid
protein can bind Secl3p, Sec23p, and Sec24p, but not Secl6p; this mutant also
fails to complement a sec31A mutant, and cannot rescue the ER to Golgi
transport defect of the temperature-sensitive sec31-2 mutant. These data
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suggest that the binding of Sec31p to Secl6p is essential, and required for ER to
Golgi transport.
The precise function of the Secl3p/Sec31p complex in the formation of
COPII vesicles remains incompletely understood, a conclusion emphasized by
recent data which suggests that Secl3p may not always be required for ER to
Golgi transport (vide infra). In particular, loss of function mutations in at
least three genes (BST1, BST2/EMP24, and BST3) have been isolated that
bypass the requirement for Secl3p in ER to Golgi transport (Elrod-Erickson
and Kaiser, 1996). These mutants have only subtle phenotypes on their own:
mutations in bstl-3 slow transport of a subset of secreted proteins from the ER
to the Golgi apparatus and increase the rate at which ER-resident proteins
Kar2p and Pdilp reach the Golgi apparatus (Schimm611er et al., 1995; Stamnes
et al., 1995; Elrod-Erickson and Kaiser, 1996). This phenotype is consistent
with a decrease in the fidelity of cargo sorting at the ER that could be
explained if BSTI-3 encode components of a checkpoint that monitors fidelity
of cargo sorting and prevents the budding of immature or improperly coated
vesicles (Elrod-Erickson and Kaiser, 1996). Alternatively, since Bst2p/Emp24p
is a major integral membrane component of ER-derived transport vesicles, it
has been suggested that Emp24p/Bst2p is a sorting receptor for a subset of
cargo molecules (Schimm6ller et al., 1995).
Secl3p may also have functions apart from vesicle formation at the ER
that are not shared by other COPII coat components. A role for Secl3p in the
regulated transport of proteins from the Golgi to the plasma membrane was
suggested by the sorting defect of the amino acid permease Gap1p observed in
secl3 mutant strains grown at temperatures permissive for ER to Golgi
transport (Roberg et al., 1997). In addition, Secl3p and a Secl3p homologue,
Seh1p, but not Sec31p are present in a subcomplex of the nuclear pore
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(Siniossoglou et al., 1996). However, secl3 mutants are not defective in
nuclear import suggesting that the association of Secl3p with the pore may
not be important for pore function. In contrast, Seh1p does appear to be
involved in nuclear pore function, since sehl mutations genetically interact
with other nuclear pore complex components (Siniossoglou et al., 1996).
A mammalian homolog of Secl3p, Secl3Rp, was discovered
serendiptously (Swaroop et al., 1994). Although SEC13R itself could not
complement a secl3-1 mutant, chimeric constructs representing the N-
terminal half of either Secl3p or Secl3Rp, and the C-terminal half of the
other protein, could complement the secl3-1 secretion defect (Shaywitz et al.,
1995). Secl3p has also been shown to localize to the area of the transitional
ER, in a distribution indistinguishable from that of mammalian Sec23 and
Sarl. The localization of Secl3 was not affected by treatment with brefeldin A
(BFA; an antibiotic that inhibits the nucleotide exchange activity required for
the binding of ARF to membranes), in contrast to the localization of coatomer
subunits; this insensitivity to BFA was shared by Sec23, and placed these two
proteins in a different category from the proteins of the COPI complex.
Finally, the ER to Golgi transport of the marker protein VSV-G was inhibited
by anti-Secl3Rp antibodies in a semi-intact cell assay, providing further
evidence that the function of Secl3 has been evolutionarily conserved (Tang
et al., 1997). Although a mammalian homolog of Sec31p has not been
identified, the finding that human Secl3Rp exhibits a strong and specific
interaction with the N-terminal region of yeast Sec31p implies the existence
of a mammalian Sec31 protein (Shaywitz et al., 1997).
D. Secl6p
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SEC16 encodes an essential, 240 kD hydrophilic protein required for the
formation of ER to Golgi transport vesicles in vivo (Kaiser and Schekman,
1990; Espenshade et al., 1995). Secl6p is tightly associated with the periphery
of the ER, and is also found on ER-derived transport vesicles that are
produced in vitro (Espenshade et al., 1995). In contrast to other COPII
components, Secl6p cannot be extracted from membranes by urea, explaining
why it has not needed to be added as a cytosolic factor to the in vitro transport
assay (Espenshade et al., 1995). SEC16 exhibits genetic interactions with the
five other COPII genes (Nakano and Muramatsu, 1989; Kaiser and Schekman,
1990; Gimeno et al., 1995) and Secl6p has been shown to bind directly to the
COPII subunits Sec23p, Sec24p, and Sec31p (Espenshade et al., 1995; Gimeno et
al., 1996; Shaywitz et al., 1997). In addition, membranes prepared from sec16
mutant strains are defective for the formation of COPII vesicles in vitro
(Cambell and Schekman, 1997); the in vitro formation of COPII vesicles is also
inhibited by the addition of Secl6p-specific antibodies to the budding reaction
(P. Espenshade, unpublished results). An attractive hypothesis is that Secl6p
on the ER membrane serves as a COPII foundation, and organizes the
recruitment and assembly of COPII coat components. This structure might be
stabilized not only by the interaction of the two COPII complexes with Secl6p,
but also by their interaction with each other (Shaywitz et al., 1997).
Furthermore, the genetic interactions between SEC16 and SAR1 suggest that
Sarlp could regulate the Secl6p-mediated coat assembly process (Nakano and
Muramatsu, 1989, Gimeno et al., 1995).
A mammalian homolog of Secl6p has not been identified; a two-
hybrid screen for such a protein is described in Chapter 3.
E. Sarlp
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SAR1 was identified as a high-copy suppressor of mutations in SEC12
and SEC16 (Nakano and Muramatsu, 1989). SAR1 is an essential gene
required for ER to Golgi transport, encodes a small GTP-binding protein most
closely related to ARF, a GTP-binding protein that regulates assembly of the
coatomer (COPI) coat (Oka et al., 1991; Barlowe et al., 1993). Sarlp is a
component of the COPII vesicle coat, and is required for its formation
(Barlowe et al., 1994; Bednarek et al., 1995).
SAR1 exhibits genetic interactions with the five other COPII
components. In addition, the activity of Sarlp has been shown to be modified
by the COPII subunit Sec23p, which functions as a Sarlp-GAP, and by Sec12p,
which functions to increase the rate of guanine nucleotide exchange by Sarlp.
Sarlp has an intrinsic guanine-nucleotide off-rate (0.07 min - 1) and GTPase
activity (0.0011 min - 1) similar to those of other small GTP-binding proteins
(Barlowe et al., 1993). Secl2p and Sec23p increase these rates (respectively) by
about an order of magnitude and Secl2p and Sec23p together increase the rate
of GTP hydrolysis by approximately 50-fold (Barlowe and Schekman, 1993;
Yoshihisa et al., 1993). Like Arflp, Sarlp requires the presence of detergents or
phospholipids for GTP binding (Barlowe et al., 1993), however, unlike other
small GTP-binding proteins, including ARF, Sarlp does not appear to require
lipid modifications for its function (Oka et al., 1991; Barlowe et al., 1993).
In vitro studies suggest that vesicle budding requires Sarlp in its GTP-
bound form (Rexach and Schekman, 1991; Oka et al., 1991; Barlowe et al. 1993;
Barlowe et al., 1994; Oka and Nakano, 1994). GTP-hydrolysis is not required
for vesicle formation since budding still occurs when nonhydrolyzable
analogs of GTP, are used, although under these conditions greater quantities
of Sec23p/Sec24p and Secl3p/Sec31p are needed (Barlowe et al., 1994). GTP-
hydrolysis by Sarlp is required for the overall transport process as the vesicle
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fusion step is sensitive to nonhydrolyzable GTP analogs (Barlowe et al., 1994;
Oka and Nakano, 1994).
Sarlp is thought to function by regulating assembly and disassembly of
the cytosolic COPII coat components. A simple model is that Sarlp in its GTP-
bound state promotes assembly of the COPII coat, while GTP-hydrolysis by
Sarlp promotes disassembly of the COPII coat (Barlowe et al., 1994). This
hypothesis is supported by in vitro data demonstrating that the COPII vesicle
coat produced in the presence of GTP is unstable, and readily dissociates from
budded vesicles, but when non-hydrolyzable analogs of GTP are substituted in
the budding reaction, the resulting COPII coat is stabilized (Barlowe et al.,
1994). These in vitro studies also indicate that COPII coat disassembly occurs
in two distinct steps: first, Sarlp rapidly hydrolyzes GTP and dissociates from
the vesicle, leaving a coat of Sec23p/Sec24p, Secl3p/Sec31p and possibly
Secl6p (Barlowe et al., 1994). Second, Sec23p/Sec24p and Secl3p/Sec31p
dissociate from the vesicle (Barlowe et al., 1994). It has not been established
whether dissociation of Secl6p from the vesicle membrane ever occurs.
A mammalian homolog of Sarlp was identified using degenerate PCR
(Kuge et al., 1995). Two clones, Sarla and Sarlb were isolated; these clones
are 91% identical to each other at the amino acid level, and are 61-67%
identical to Sarlp. Immunoelectronmicroscopy using antibodies raised
against Sarla (and also reactive with Sarlb) demonstrated that Sarl, like
mammalian Secl3 and Sec23, is found in the region of the transitional ER.
Inhibition of the ER to Golgi transport of the marker protein VSV-G in vivo
and in vitro using a deliberately designed dominant negative Sarl mutant
demonstrated the requirement for Sarl in mammalian ER to Golgi transport.
F. Secl2p
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Secl2p is an integral membrane protein that influences vesicle budding
at the ER, but is not itself incorporated into vesicles. SEC12, an essential gene
required for the formation of ER-derived vesicles, encodes a type II
transmembrane protein that localizes to the ER, but is absent from vesicles
produced in vitro (Nakano et al., 1988; Kaiser and Schekman, 1990;
Nishikawa and Nakano, 1993; Barlowe et al., 1994). The cytosolic domain of
Secl2p is essential and stimulates guanine-nucleotide exchange by Sarlp,
whereas the luminal domain appears to be less important since truncation of
this domain does not greatly interfere with SEC12 function (d'Enfert et al.,
1991a; Barlowe and Schekman, 1993). The cytosolic domain of Secl2p may
also function to recruit Sarlp to the ER membrane since overexpression of
Secl2p depletes Sarlp from the cytosol and increases the membrane-
associated pool of Sarlp (d'Enfert et al., 1991b; Barlowe et al., 1993).
Recruitment may not involve direct binding between Secl2p and Sarlp since
a stable association between these proteins has not been observed. However,
if Sarlp in its GTP-bound state has a high affinity for the ER membrane,
Secl2p may effect recruitment simply by stimulating nucleotide exchange. It
appears that for Sarlp to be properly activated, the exchange activity of Secl2p
must be in proximity to the ER membrane since truncations of Secl2p that
liberate a soluble exchange activity inhibits vesicle budding from the ER. This
inhibition can be overcome by the addition of increased amounts of Sarlp
(Barlowe and Schekman, 1993).
ER to Golgi Transport IV: Cargo sorting during COPII vesicle formation
If important sorting decisions occur during the formation of COPII
vesicles, as suggested above, it is likely that the COPII proteins themselves
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participate in the selection process, and communicate critical information
about the selection of cargo to the budding vesicles, possibly through
interactions with transmembrane proteins. Coat-mediated sorting is well
documented during the formation of clathrin and COPI-mediated vesicles in
mammalian cells (Schekman and Orci, 1996). In these coats, sorting is
mediated by binding of integral membrane cargo proteins or sorting receptors
to subunits of the clathrin or the COPI coat (Ohno et al., 1996; Cosson and
Letourneur, 1994). Thus far, no binding between a COPII subunit and a cargo
protein has been demonstrated, although it has been suggested that Sec23p
may sample cargo proteins at the ER during the initial steps of vesicle
formation (Schekman and Orci, 1996).
The analysis of sorting during vesicle formation at the ER is
complicated by the absence of a defined sorting signal or sorting receptor. No
common signal required for exit from the ER has been defined and mutants
blocked in ER to Golgi transport did not reveal a candidate sorting receptor.
One attractive hypothesis is that the sorting of integral membrane proteins is
mediated by the interaction of these proteins with the COPII coat. In this
scheme, the coat complex would collectively function as a "receptor surface,"
with many potential sites available for interaction with cargo membrane
proteins. The sorting of soluble cargo molecules requires additional
assumptions; one possibility is that soluble cargo binds to integral plasma
membrane proteins, and follows them through the secretory pathway.
Alternatively, there may be a family of integral membrane proteins that
function as "sorting receptors," binding on the one hand to COPII proteins,
and on the other, to soluble cargo molecules. Emp24p/Bst2p, an integral ER
membrane protein, has been suggested to be such a receptor. Emp24p was
cloned because it is also a prominent component of ER-derived vesicles
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(Schimm6ller et al., 1994); a chromosomal deletion of EMP24 does not impair
growth but slows ER to Golgi transport of a subset of cargo proteins (invertase
and Gas1p), consistent with a role in segregating particular cargo molecules
into the vesicles. However, direct binding of Emp24p to cargo proteins has
not been observed.
Emp24p/Bst2p and a second ER membrane protein, Bstlp, were also
identified because their deletion allows cells to grow in the absence of Secl3p
(Elrod-Erickson and Kaiser, 1996; vide supra, "Sec31p/Secl3p"). Strains
deleted for Bstlp or Emp24p/Bst2p have a decreased fidelity of cargo protein
sorting, evidenced by a kinetic defect in the export of a secreted protein
(invertase) from the ER, and secretion of the normally ER-retained proteins
Kar2p, Pdilp, and an invertase mutant defective in signal sequence cleavage
(Elrod-Erickson and Kaiser, 1996). Since bstl and bst2 mutants affect both
protein sorting and the requirement for a COPII coat component, Bstlp and
Emp24p/Bst2p may constitute part of a checkpoint that monitors both protein
sorting and COPII coat assembly, before allowing vesicle formation to proceed
(Elrod-Erickson and Kaiser, 1996).
ER to Golgi Transport V: Towards a model for COPII vesicle formation
Biochemical and molecular analysis of the proteins required for vesicle
formation suggest an outline for the pathway for COPII coat assembly. The
first step in vesicle formation at the ER is thought to be guanine-nucleotide-
exchange by Sarlp and recruitment of Sarlp to the ER membrane. This step is
probably stimulated by Secl2p. Next, Sarlp in its GTP-bound, membrane-
associated form may recruit the coat components Sec23p/Sec24p and
Secl3p/Sec31p to Secl6p. This complex could then nucleate further
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polymerization of coat subunits to eventually form a vesicle bud. This model
is developed further in Chapter V.
ER to Golgi Transport VI: Future directions
The process of vesicle formation at the ER remains incompletely
understood, and many fundamental questions remain. For example, how is
the site of budding determined? What is the order of component assembly
on the ER membrane? How is this assembly process regulated? Are there
other factors required for vesicle assembly in vivo that, like Secl6p, have
escaped detection by the in vitro assay? What is the relationship between the
assembly of the coat structure and the deformation of the ER membrane from
a flat surface into a vesicle bud? What is the mechanism of vesicle scission?
What is the basis for cargo selection? What regulates dissociation of the coat?
Resolution of these questions will require both the refinement of the in vitro
assay as well as the isolation of additional mutants.
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Chapter II
Human SEC13Rp functions in yeast and is located on
transport vesicles budding from the endoplasmic reticulum
-34-
PREFACE
This chapter has been published in its entirety in the Journal of Cell
Biology as: David A. Shaywitz, Lelio Orci, Mariella Ravazzola, Anand
Swaroop, and Chris A. Kaiser (1995): Human SEC13Rp functions in yeast and
is located on transport vesicles budding from the endoplasmic reticulum. J.
Cell Biol. 128:769-777.
A. Swaroop provided the human SEC13R clone; L. Orci and M.
Ravazzola performed the immunoelectronmicroscopy.
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ABSTRACT
In the yeast S. cerevisiae, Secl3p is required for intracellular protein
transport from the endoplasmic reticulum (ER) to the Golgi, and has also
been identified as a component of the COPII vesicle coat structure. Recently, a
human cDNA encoding a protein 53% identical to yeast Secl3p has been
isolated. In this report, we apply the genetic assays of complementation and
synthetic lethality to demonstrate the conservation of function between this
human protein, designated SEC13Rp, and yeast Secl3p. We show that two
reciprocal human/yeast fusion constructs, encoding the N-terminal half of
one protein and the C-terminal half of the other, can each complement the
secretion defect of a secl3-1 mutant at 360 C. The chimera encoding the N-
terminal half of the yeast protein and the C-terminal half of the human
protein is also able to complement a SEC13 deletion. Overexpression of either
the entire human SEC13Rp protein or the chimera encoding the N-terminal
half of the human protein and the C-terminal half of the yeast protein
inhibits the growth of a secl3-1 mutant at 24°C; this growth inhibition is not
seen in a wild-type strain nor in other sec mutants, suggesting that the N-
terminal half of SEC13Rp may compete with Secl3-1p for a common target.
We show by immunoelectronmicroscopy of mammalian cells that SEC13Rp
-- like the putative mammalian homologues of the COPII subunits Sarlp and
Sec23p -- resides in the region of the transitional ER. We also show that the
distribution of SEC13Rp is not affected by brefeldin A treatment. This report
presents the first demonstration of a putative mammalian COPII component
functioning in yeast, and highlights a potentially useful approach for the
study of conserved mammalian proteins in a genetically tractible system.
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INTRODUCTION
Proteins secreted by eukaryotic cells are vectorially transported from
the ER through the Golgi apparatus to the cell surface in a series of steps
mediated by membrane-bounded vesicles (Palade, 1975). The ability to study
vesicle budding and fusion events in both yeast and mammalian systems has
greatly facilitated the detailed molecular study of intracellular protein
transport (Pryer et al., 1992; Rothman and Orci, 1992; Kaiser, 1993).
Vesicular transport between adjacent Golgi stacks has been extensively
investigated in mammalian systems, and a clear model has now emerged
(Ostermann et al., 1993). In this scheme, transport is initiated by the
attachment of the small molecular weight GTP-binding protein, ADP-
ribosylation factor (ARF), to the donor compartment (Donaldson et al., 1992;
Helms and Rothman, 1992; Helms et al., 1993). Bound ARF-GTP stimulates
the recruitment of coatomer, a seven-subunit protein complex, from the
cytosol, and budding occurs when coatomer binds (Donaldson et al., 1992; Orci
et al., 1993b,c; Palmer et al., 1993; Hara-Kuge et al., 1994). Finally, the
hydrolysis of ARF-GTP, presumably at the target membrane, results in coat
disassembly, and permits the vesicle to fuse (Tanigawa et al., 1993; Elazar et
al., 1994).
Both ARF and the P-COP subunit of coatomer have also been
implicated in ER to Golgi transport. Transport of the vesicular stomatitis
virus glycoprotein (VSV-G) from the ER is inhibited by the overexpression of
a dominant negative ARF mutant (T31N) in cultured cells (Dascher and
Balch, 1994). VSV-G transport from the ER is also inhibited by 3-COP-specific
antibodies in both microinjected (Pepperkok et al., 1993) and digitonin-
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permeabilized (Peter et al., 1993) cells. These data suggest a possible role for
coatomer in ER to Golgi transport.
Vesicular transport from the ER to the Golgi has been extensively
studied in the yeast S. cerevisiae, and more than 20 genes have been
implicated in this process (Kaiser, 1993). One of these genes, SEC21, is
homologous to the y-subunit of coatomer (Hosobuchi et al., 1992). However,
purification of S. cerevisiae transport-competent vesicles synthesized in vitro
has revealed a coat complex containing five proteins previously implicated in
vesicle-formation - Secl3p, Sec23p, Sec24p, Sec31p and Sarlp -- but not Sec21p
(Barlowe et al., 1994). Secl3p and Sec23p were initially identified by
temperature-sensitive mutations which block vesicle formation at the non-
permissive temperature (Novick et al., 1980; Kaiser and Schekman, 1990).
Sec24p and Sec31p were identified by the physical association with Sec23p and
Secl3p, respectively (Hicke et al., 1992; Salama et al., 1993). Sarlp was initially
isolated as a suppressor of a mutation in the vesicle formation gene SEC12
(Nakano and Muramatsu, 1989). Since none of these proteins show any
apparent homology to subunits of the mammalian coatomer, the yeast coat
complex has been designated COP II (Barlowe et al., 1994).
Mammalian genes showing significant sequence similarity to three
COPII proteins have now been identified. Using degenerate PCR, Kuge et al.
(1994) isolated two different mammalian clones encoding proteins with
predicted amino acid sequences 61% identical to the sequence of the yeast
Sarlp protein. The export of VSV-G protein from the ER is inhibited by
overexpression of a dominant negative Sarlp mutant (T39N), as well as by
the incubation of semi-intact cells with Sarlp-specific antibody. Immuno-
electronmicroscopy (EM) analysis reveals that Sarlp is highly enriched on
vesicular carriers in the transitional region of the ER, consistent with a role in
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ER to Golgi transport. A similar distribution was also seen in mammalian
cells for Sec23p, using cross-reacting antibodies raised against the yeast Sec23p
protein (Orci et al., 1991). A mouse Sec23p homologue, encoding a product
40% identical to Sec23p, was recently discovered (Wadhwa et al., 1993); the
relationship between this protein and the protein that cross-reacts with the
anti-yeast-Sec23p antibody has not yet been established. Finally,
Swaroop et al. (1994) have identified a human gene, SEC13R, that encodes a
protein with 53% identity and 70% similarity to the amino acid sequence of
the yeast COPII protein Secl3p.
The extensive genetic study of secretion provides us with the tools to
explore the relationship between the function of a yeast COPII component
and the function of a potential mammalian homolog. Perhaps the most
direct way to study this relationship is to examine the behavior of the human
protein in yeast -- particularly yeast bearing a mutation in the corresponding
endogenous gene. Not only is this approach useful in helping us understand
and compare the process of vesicular transport in yeast and mammalian cells,
but evidence of interchangability is also required for the rigorous
demonstration of homology (Tugendreich et al., 1994).
To investigate the functional relationship between the human protein
SEC13Rp and yeast Secl3p, we examined the effect of human SEC13R
expression in mutant and wild-type yeast. Through the application of two
different genetic criteria -- complementation (Benzer, 1962) and synthetic
lethality (Dobzhansky, 1946; Sturtevant, 1956; Huffaker, 1987) -- we have been
able to show that SEC13R exhibits SEC13 function, and may therefore be
designated a mammalian homolog of SEC13. Although SEC13R itself does
not complement the temperature-sensitive yeast mutant secl3-1, two
reciprocal human/yeast chimeras, encoding the N-terminal of one protein
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and the C-terminal half of the other, are each able to rescue the secl3-1
secretion defect at 36°C; one of the chimeras can also complement a SEC13
deletion. Furthermore, overexpression of the entire mammalian gene
exhibited a negative effect in secl3-1 mutants but not in either wild-type yeast
or in other sec mutants; this result, an example of the genetic phenomenon of
synthetic lethality, strongly suggests that in yeast, Secl3p and SEC13Rp
participate in the same pathway. Together, the genetic data provide
compelling evidence that human SEC13Rp can function in yeast; SEC13Rp
thus represents the first putative mammalian homolog of a yeast COPII
component to fulfill this criterion.
Immuno-EM analysis of pancreatic cells using antibodies raised against
SEC13Rp demonstrate that SEC13Rp is concentrated in the transitional ER, in
a distribution indistinguishable from that previously observed for Sec23 in
the same cell type (Orci et al., 1991; Orci et al., 1993a). The distribution of
SEC13Rp is not affected by brefeldin A treatment, in contrast to the result seen
for coatomer (Orci et al., 1993a).
As a whole, our data not only support the existence of a mammalian
COPII structure, but also emphasize the utility of heterologous gene
expression as tool to study conserved proteins (Whiteway et al., 1993; Thukral
et al. 1993).
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MATERIALS AND METHODS
Strains, Materials, and General Methods
Yeast strains used in this study are CKY8 (MATa leu2-3,112 ura3-52), RHY305
(MATa leu2-3,112 ura3-52 secl3-1 GAL), DSY174 (MATa leu2-3,112 ura3-52
GAL [pRS315, pGAL-SEC13R]), DSY223 (MATa secl2-4 leu2-3,112 ura3-52 GAL
[pRS315, pGAL-SEC13R]), DSY216 (MATa secl3-1 leu2-3,112 ura3-52
GAL[pRS315, pGAL-SEC13R]), DSY228 (MATa sec16-2 leu2-3,112 ura3-52
GAL[pRS315, pGAL-SEC13R]), DSY232 (MATa secl7-1 leu2-3,112 ura3-52 GAL
[pRS315, pGAL-SEC13R]), DSY236 (MATa secl8-1 leu2-3,112 ura3-52 GAL
[pRS315, pGAL-SEC13R]).
Yeast culture, genetic manipulations, and molecular techniques were
as described (Sambrook et al., 1989; Rose et al., 1990). Mammalian cell extracts
were prepared by standard methods (Harlow and Lane, 1988). Materials were
obtained from Sigma Chemical Company (St. Louis, MO) unless stated
otherwise.
Gel electrophoresis was performed according to the Laemmli SDS-
PAGE method using 10% polyacrylamide (Laemmli, 1970). Affinity purified
anti-SEC13Rp antibody was used at 1:10,000 dilution. Secondary antibody was
goat-anti-rabbit IgG, conjugated to HRP (Amersham Corp., Arlington Heights,
IL), at a 1:10,000 dilution. Filter-bound antibodies were then detected by
peroxidase-catalyzed chemiluminescence (ECL kit, Amersham Corp.).
The monkey fibroblast cell line COS was grown in complete medium
consisting of Dulbecco's modified Eagle's medium with 10% fetal bovine
serum, 2 mM glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin.
The chinese hamster ovary cell line CHO was grown in complete medium
consisting of Ham's F12 medium with 5% fetal bovine serum, 2 mM
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glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin. Both cells lines
were maintained at 370 C in a 5% CO2 cell incubator.
Generation of Chimeric Constructs
The cloning of the SEC13R gene has been previously described (Swaroop et
al., 1994). A Clal site was introduced at nucleotide 449 in the SEC13R cDNA,
corresponding to the Clal site present in SEC13 at nucleotide 488 (Pryer et al.,
1993), using the oligonucleotide-directed mutagenesis method of Kunkle et al.
(1987). The (antisense) primer used for this mutagenesis was: 5'-
GGCAATGGTGTGAGCATCGATGATCTTCTTTACTTC-3'; altered
nucleotides are underlined. In addition to introducing a restriction site, this
procedure also altered two amino acids, changing Asnl46 -> Ile and Asnl47 ->
Asp (Fig. 1). Both mutagenized and wild-type forms were cloned into the
vector pCD43 directly downstream of the GAL10 promoter. Since both forms
behaved identically in all assays described, only the strain containing the
mutagenized form (designated pGAL-SEC13R) is shown. pCD43 is a modified
pRS316 (ARS CEN URA3) vector (Sikorski and Hieter, 1989) in which
divergent GALl and GALIO promoters have been introduced between the
BamHI and EcoRI sites in the polylinker. The N-terminal Secl3p/C-terminal
SEC13Rp chimera was constructed by linking a BamHI/ClaI SEC13 5'
fragment with a Clal-HindIII SEC13R 3' fragment. The reciprocal chimera
was constructed by linking a 5' RI-Clal SEC13R fragment with a ClaI-KpnI
SEC13 fragment. The SEC13 plasmid was generated by first introducing a
BamHI site immediately 5' to the initial ATG by PCR, using pCK1313 as a
template (Pryer et al., 1993) and 5'-
GCGGATCCAACCATGGTCGTCATAGCTAATGC-3' as the (sense) primer.
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The resulting BamHI/SacI fragment was cloned into pCD43, and was able to
rescue secl3-1 mutants at the restrictive temperature.
Chimera Complementation/Inhibition Assays
All constructs were transformed into RHY305. The vector pRS315 (Sikorski
and Hieter, 1989) was co-transformed in all experiments, rendering all strains
effectively prototrophic. Transformants were then assayed at
36 0(complementation) or at 24°(inhibition) on synthetic minimal media
(Difco) supplemented with either 2% glucose or 2% galactose.
Radiolabelling and Immunoprecipitations
Cells were pre-grown at 24°C in selective SC medium containing 2%
raffinose, and were induced by the addition of 2% galactose three hours prior
to the start of labeling. One hour before labelling, cells were shifted to 36°C.
8x10 7 exponentially growing cells (4 OD600 units) were radiolabelled in
supplemented SD medium by incubating with 30 gCi 3 5S-methionine per
OD600 unit (Express protein labelling mix [NEN, Boston, MA], spec. activity
1200 Ci/mmol). Samples were chased by the addition of 1/100 volume of a
solution containing 0.1M ammonium sulfate, 0.3% cysteine, 0.4%
methionine. Labelled samples of 1 OD600 unit of cells were collected into
chilled tubed containing one volume of 40 mM sodium azide. Protein
extracts were prepared in 30 ul ESB by vigorous agitation with glass beads.
Extracts were diluted with 1 ml IP buffer (50 mM Tris-C1, pH 7.5, 150 mM
NaC1, 1% Triton X-100, 0.2% SDS), absorbed for 20 minutes with 50 ul 10% S.
aureus cells (Sigma), and cleared by centrifugation at 12,000 g for five minutes.
0.5 ul anti-CPY antibody was added, and extracts were rotated for one hour at
room temperature. Immune complexes were collected by adding 25 ul 50%
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Protein A/Sepharose (Pharmacia, Piscataway, NJ) per sample, and incubating
an additional hour at room temperature. Protein A/Sepharose pellets were
washed twice with IP buffer, and twice with detergent-free IP buffer (50 mM
Tris-C1, pH 7.5, 150 mM NaC1). Protein was released into 30 ul ESB by heating
to 1000C for 2 minutes. 12 ul of the supernatant were separated by SDS-PAGE
and visualized by fluorography (Harlow and Lane, 1989).
Generation of SEC13-deletion strain
RHY297 (MATa secl3-A1 ura3-52 leu2-3,112 ade2-101 ade3-24 [pKR4 (ARS
CEN LEU2 ADE3 SEC13)]) carries a secl3 allele (secl3-A1) in which the entire
SEC13 coding sequence is deleted. RHY297 was constructed by R. Hammer as
follows. A 50-nucleotide oligomer (SEC13-N1: 5'-CAT TTT AAA TTC TTG
ATA CTC TTC ACG GAT CCG TAT GCT GAT ATA AAA TTA TCT GTT
ATC-3') consisting of 28 and 26 nucleotides complementary to the 5' and 3'
untranslated region of SEC13 respectively and 6 nucleotides creating a BamHI
site (underlined) was used to mutagenize pKR1 (CEN SEC13 URA3) (K.
Roberg, unpublished) using the protocol of Kunkel et al. (1987). pRH102 is a
mutagenesis product that lacks the entire SEC13 coding region as judged by
restriction mapping, but retains SEC13 flanking DNA. A 5 kb hisG-URA3-
hisG marker cassette (modified Alani et al. [1987]); S. Elledge, unpublished)
was inserted into the BamHI site of pRH102 to make pRH104. The 6kb EcoRI-
SacI fragment of pRH104 was transformed into KRY5p4 (MATa secl3-1 ura3-
52 leu2-3,112 ade2-101 ade3-24 [pKR4 (ARS CEN LEU2 ADE3 SEC13 )]) (K.
Roberg unpublished). Ura+ transformants that are unable to sector at 24°C
were selected. RHY297 is a non-sectoring, Ura- derivative, selected by plating
transformants on medium containing 5-fluoro-orotic acid (Boeke et al., 1984).
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The chimera-suppressed SEC13-deletion strain was obtained by
transformation of RHY297 using the construct encoding the N-terminal
Secl3p/C-terminal SEC13Rp chimera, described above, and then isolating
white (pKR4-) colonies.
Generation of Antibodies to the SEC13Rp Protein
SEC13Rp antiserum was elicited against a hybrid protein composed of the
entire SEC13R coding region fused to Staphylococcal protein A, using the
pRIT33 vector (Nilsson and Abrahmsen, 1990). Hybrid protein was prepared
from E. coli extracts and antibody to this protein produced in rabbits, as
described previously (Griff et al., 1992). Antiserum was affinity purified using
a :B-galactosidase-SEC13Rp hybrid protein constructed by fusing the entire
coding sequence of SEC13R to the lacZ gene in the pEX2 vector (Stanley and
Luzio, 1984). The hybrid protein was isolated and used for affinity
purification of the antibody as described (Pryer et al., 1993). The affinity-
purified anti-sera was concentrated using a centricon-30 microconcentrator
(Amicon).
Immunofluorescence
COS cells or CHO cells were grown in complete medium on 12 mm glass
coverslips for 2 days prior to recovery. Cells were fixed in 2%
paraformaldehyde, and permeabilized in 0.1% Triton X-100, 0.02% SDS.
Affinity-purified anti-SEC13Rp was used at a dilution of 1:50 in PBS/10% FBS
in the presence of 0.2% saponin; 20 antibody (FITC-conjugated goat-anti-rabbit;
Boehringer) was added at a concentration of 1:250, using the same buffer
composition. Coverslips were viewed by epifluorescence with a Zeiss
Axioskop.
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Immunoelectronmicroscopy
Rat pancreatic acinar tissue and isolated islets of Langerhans fixed in 1%,
phosphate-buffered glutaraldehyde were processed for cryoultramicryotomy
according to Tokuyasu (Tokuyasu, 1986). SEC13Rp was localized by the
protein A-gold method (Roth et al., 1978). Antibody dilution = 1:50; gold
particle size = 10 nm. After immunolabeling, the cryosections were stained
with uranyl acetate. Brefeldin A (BFA) treatment of insulin cells was
performed as previously described (Orci et al., 1993a).
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RESULTS
Complementation of secl3-1 defect by humanlyeast chimeras
The high degree of sequence similarity between Secl3p and SEC13Rp
(Fig. 1), distributed along the length of the two proteins, encouraged us to ask
whether SEC13R could functionally substitute for a defective SEC13 gene.
The secl3-1 allele represents a single point mutation in SEC13, and cannot
support growth at temperatures above 300 C (Pryer et al., 1993). The
overexpression of SEC13R cDNA from a galactose-inducible promoter in a
secl3-1 strains did not restore viability at 360 C (Fig. 2a). However, significant
growth was observed at 360C upon the galactose-induced overexpression of a
chimeric construct encoding the N-terminal half of yeast Secl3p and the C-
terminal half of human SEC13Rp. This chimera was constructed by first
creating a Clal restriction site at nucleotide 449 of the human cDNA,
corresponding to a naturally occurring Clal site in nucleotide 488 of the yeast
gene; each Clal site occurs roughly in the middle of the protein coding
sequence. The N-terminal-encoding half of yeast SEC13 was then fused to the
C-terminal-encoding half of human SEC13R, using the Clal site as a junction
(Fig. 1). Induction of a construct encoding only the N-terminal half of yeast
Secl3p was unable to complement a secl3-1 defect (data not shown; Pryer et
al., 1993), suggesting that the C-terminal region of Secl3p is functionally
required, and is not dispensable (see Discussion). The galactose-induced
overexpression of the reciprocal chimeric construct, encoding the N-terminal
half of human SEC13Rp and the C-terminal half of yeast Secl3p, also
complemented the secl3-1 defect, though somewhat less efficiently (Fig. 2a).
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To demonstrate that both chimeras correct the secl3 secretion defect,
the transport of the marker protein carboxypeptidase Y (CPY) was monitored
by pulse-chase analysis. CPY is targeted to the vacuole via the ER and Golgi.
The core-glycosylated pl form of the enzyme can be resolved from the form
that has received Golgi-specific modification (p2) and the mature form (M)
that has been proteolytically cleaved in the vacuole (Stevens et al. 1982).
Cells were grown in exponential phase at 24°C in media containing raffinose,
induced for 2 hours with galactose, then shifted to 36 0C for one hour. Cells
were next pulse-labeled for 10 minutes, then chased with excess methionine
and cysteine. Lysates were prepared, and immunoprecipitated with anti-CPY
antibodies. In secl3-1 mutants, at 360 C, CPY is unable to exit the ER, and exists
almost exclusively in the pl form (Fig. 3). However, upon the galactose-
induced overexpression of either the N-terminal yeast Secl3p/C-terminal
human SEC13Rp chimera or the N-terminal human SEC13Rp/C-terminal
yeast Secl3p chimera, CPY is able to exit the ER, progress through the Golgi,
and arrive in the vacuole (Fig. 3). The observation that either half of
SEC13Rp can supply sufficient Secl3p activity to permit a yeast/human
chimeric protein to complement the temperature-sensitive secretion defect of
a secl3-1 mutant suggests that SEC13Rp and Secl3p are functionally similar.
The ability of SEC13Rp to exhibit Secl3p function was illustrated
further by the viability of a yeast strain expressing an N-terminal yeast
Secl3p/C-terminal human SEC13Rp chimeric protein, but containing no
endogenous Secl3p (Fig. 4). To determine whether a yeast/human chimera
could complement a SEC13 deletion, the N-terminal Secl3p/C-terminal
SEC13Rp construct was transformed into the indicator strain RHY297.
RHY297 is an ade2- ade3- strain in which the entire SEC13 coding sequence
has been deleted; the strain carries a plasmid bearing SEC13, LEU2 and ADE3.
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The strain is normally dependent upon the plasmid-encoded SEC13, and is
also colored, reflecting the accumulation of a red intermediate resulting from
ade2-blocked adenine biosynthesis (Jones and Fink, 1981; Koshland et al.,
1985). However, upon transformation with a plasmid capable of
complementing the SEC13 deletion, the SEC13, ADE3, LEU2 plasmid is no
longer required, and can be lost during colony growth. Plasmid loss is
detected by the appearance of white sectors; in the absence of the ADE3 gene
product, the adenine biosynthetic pathway is blocked at an earlier stage, prior
to the ade2 block, and the red-colored intermediate is not produced.
RHY297 was transformed with the construct encoding the N-terminal
Secl3p/C-terminal SEC13Rp chimeric protein, grown on plates containing
galactose but not leucine (to maintain selection for the LEU2 marker), and
analyzed by western blot using affinity-purified anti-Secl3p antibodies as a
probe (Pryer et al., 1993). Yeast Secl3p itself has a predicted molecular weight
of approximately 33 kD. The yeast/human chimera, however, has a slightly
heavier predicted molecular weight, since the human C-terminal region is 20
amino acids longer than the corresponding region of the yeast protein.
Extracts from wild-type cells revealed a single band at 33 kD, representing
endogenous Secl3p (Fig. 3). Extracts from RHY297 cells transformed with the
yeast/human chimeric construct revealed two bands: a 33 kD band
representing Secl3p, and a slower-migrating band representing the chimeric
construct.
When the RHY297 strain containing the chimeric construct was then
grown on plates containing galactose plus rich media (thus no longer
maintaining selection for the LEU marker on the SEC13 plasmid), white
sectors appeared, indicating that in the presence of the chimeric construct, the
Secl3p-encoding plasmid was no longer necessary. When colonies from the
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white sectors were isolated and analyzed by western blot, a single band
appeared at the location expected for the chimeric protein (Fig. 4). These data
demonstrate that the N-terminal Secl3p/C-terminal SEC13Rp chimeric
protein can functionally substitute for an absent Secl3p protein.
Furthermore, since the chimeric product can functionally replace the
endogenous protein, the SEC13R-encoded C-terminal region must exhibit
activity similar to that found in the C-terminal region of Secl3p.
Complementation of a SEC13 deletion was not noticeably detected in a yeast
strain transformed with the reciprocal chimera, a result consistent with the
weaker activity exhibited by this construct in the suppression of a secl3-1
growth defect (Fig. 2a).
Human SEC13R specifically inhibits growth of a secl3-1 mutant
In the course of the complementation experiments, we discovered that
the galactose-induced overexpression of SEC13Rp inhibited the growth of a
secl3-1 mutant strain at permissive temperatures. Although this strain
normally grows well at 24°C, cell growth was dramatically inhibited by the
induction of SEC13Rp (Fig 2b). Galactose-induced overexpression of SEC13Rp
produced no evident phenotype in a wild-type strain or in strains carrying
temperature-sensitive alleles of SEC12, SEC16, SEC17, or SEC18, suggesting
that the observed effect was specific for the secl3-1 strain (Fig. 5).
Overexpression of the chimera encoding the N-terminal half of SEC13Rp and
the C-terminal half of Secl3p also inhibited growth of the secl3-1 strain at
24°C (Fig. 2b), implying that the N-terminal half of SEC13Rp was responsible
for this growth inhibition. Consistent with this interpretation, the N-
terminal Secl3p/C-terminal SEC13Rp chimera produced no obvious
phenotype at 24°C. The inhibitory effect of SEC13Rp expression on the
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growth of a secl3-1 strain at 24°C suggests that both SEC13Rp and Secl3-1p
may interact with the same protein or substrate, and thus may participate in
the same step or pathway. For example, SEC13Rp may titrate out a Secl3p
target by binding to it unproductively.
Subcellular localization of SEC13Rp
To explore further the function of SEC13Rp in mammalian cells, we
raised rabbit serum against a hybrid protein of Staphylococcus protein A fused
to SEC13Rp. Antibodies specific for SEC13Rp were affinity purified using a
hybrid protein composed of E. coli D-galactosidase fused to SEC13Rp. Purified
antibodies recognized a single prominent band with the expected molecular
weight of approximately 36 kD on immunoblots of lysates from wild-type
yeast overexpressing SEC13Rp or from CHO or COS cells (Fig. 6).
Immunoblots of wild-type yeast lysates did not show any pronounced bands;
this shows that the affinity-purified anti-SEC13Rp antibodies do not cross-
react with the yeast Secl3p protein.
The affinity-purified antibody was used to determine the subcellular
localization of SEC13Rp. By indirect immunofluorescence, SEC13Rp
exhibited a "diamond ring" appearance, encircling the nucleus in both CHO
and COS cells (Fig. 7a, b). To determine more precisely the subcellular
distribution of SEC13Rp, we used immunoelectronmicroscopy, and focused
on two cell types with well-developed secretory compartments, the insulin
and the acinar cells of the pancreas (Fig. 8a, b). In both of these cell types,
SEC13Rp was found concentrated in the transitional area of the ER (Table 1),
in a distribution indistinguishable from that previously observed for
mammalian Sec23p in the same cells (Orci et al., 1991). Furthermore, as
previously observed for mammalian Sec23p (Orci et al., 1993a), the
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distribution of SEC13Rp was not altered by brefeldin A treatment, and
remained excluded from coatomer-rich areas of "BFA-bodies" (Fig. 9). These
data are consistent with the view that SEC13Rp and mammalian Sec23p are
not constituents of the coatomer, but rather are both components of a
different structure -- most likely, mammalian COPII -- involved in ER to
Golgi transport.
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DISCUSSION
This report provides strong evidence that the function of Secl3p has
been highly conserved through evolution. In yeast, Secl3p is required for
vesicle budding from the ER, and has been identified as a constituent of the
vesicle-coating protein complex designated COPH (Pryer et al., 1993; Barlowe
et al., 1994). We have shown that two reciprocal human/yeast chimeric Secl3
constructs can each complement a secl3-1 mutant, and can rescue both the
growth defect and the secretion defect. We have also shown that one of these
chimeric constructs can complement a deletion of SEC13. In addition, we
have demonstrated that the human SEC13Rp protein itself inhibits the
growth of a secl3-1 mutant, but not of either wild-type yeast or mutants in
SEC12, SEC16, SEC17, or SEC18. We also show that SEC13Rp is located in the
transitional ER, in a distribution identical to that previously observed for
mammalian Sec23. Finally, we show that the cellular distribution of
SEC13Rp is insensitive to BFA treatment, consistent with the behavior
previously observed for mammalian Sec23, but not for coatomer
components.
Complementation of the growth defect of a secl3-1 mutant at 360 C
represents a stringent assay that requires no presumptions about the specific
function of Secl3p. The ability of both yeast/human chimeric proteins to
complement a secl3-1 mutant implies that in both cases, the human region of
the chimeric protein is fulfilling the function or functions normally
performed by the corresponding region of the yeast protein. The ability of
both chimeras to restore CPY transport in a secl3-1 strain specifically
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demonstrates complementation of the ER to Golgi secretion defect
characteristic of secl3-1 mutants.
If the two reciprocal chimeras complement both the growth defect and
the secretion defect of a secl3-1 mutant, then why does the entire SEC13R
cDNA not complement either defect? We believe that there are at least two
contributing factors. First, we would suggest that although both halves of
human SEC13Rp can function in yeast, they do not function at quite the same
level of wild-type Secl3p; this would explain why the full-length SEC13Rp
protein, representing the sum of two sub-optimal halves, cannot rescue the
secl3-1 secretion defect. Second, we would propose that in a secl3-1 strain, the
N-terminal region of SEC13Rp is toxic, resulting in the growth defect
observed at 24°C in strains expressing either the full length SEC13Rp protein
or the N-terminal SEC13Rp/C-terminal Secl3p protein. Although the
precise reason for this toxicity is not known, the observation that it is only
seen in a secl3 mutant, and not in either a wild-type strain or in other sec
mutants, suggests a synthetic lethal interaction between SEC13R and secl3-1,
and implies that secl3-1p and SEC13Rp participate in the same pathway, and
perhaps compete for a common target. The ability of the N-terminal
SEC13Rp/C-terminal Secl3p protein to rescue a secl3-1 secretion defect at 360 C
suggests that the toxicity associated with the N-terminal region of SEC13Rp
develops over a period of time longer than that encompassed by the pulse-
chase assay.
Localization of SEC13Rp to the transitional ER and associated transport
vesicles represents an important observation. These data not only situate
SEC13Rp in precisely the area expected for a mammalian protein involved in
ER to Golgi transport, but also emphasize that SEC13Rp is concentrated at this
level. This is strong evidence that SEC13Rp is specifically involved in ER to
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Golgi transport. If SEC13Rp is in fact a component of a mammalian COPII
complex, then these data would suggest that COPII is involved solely in
transport between the ER and the Golgi, and, unlike coatomer, is not
involved in intra-Golgi transport.
The observation that SEC13Rp does not redistribute upon BFA
treatment is encouraging because it places SEC13Rp and mammalian Sec23p
in a different category from all the known coatomer components.
Furthermore, since BFA is known to inhibit the binding of ARF to donor
membranes, it is tempting to speculate that ARF is not involved in the
recruitment of SEC13Rp and mammalian Sec23p; perhaps this function is
fulfilled by Sarlp.
Functional complementation of a yeast mutant by a human/yeast
chimera has been reported for a number of different genes. Mutants in yeast
genes encoding the transcription factor SWI2p (Khavari et al., 1993), the
nucleotide exchange factor CDC25p (Wei et al., 1992), the RNA-binding
protein SNP1p (Smith and Barrell, 1991), and the ABC-transporter STE6p
(Teem et al., 1993) have all been complemented by chimeric constructs
consisting of fused regions of the wild-type yeast gene and its putative
mammalian homologue. Not only does such complementation demonstrate
the conservation of function between yeast and human gene products, but it
can also allow for the detailed study of the mammalian protein, as is
illustrated by the work by Teem et al. (1993) on the cystic fibrosis
transmembrane conductance regulator.
Together, the data presented in this report argue that the function of
Secl3p has been conserved from yeast to humans, and also support the
existence of a mammalian COPII complex. More generally, our results
emphasize that chimera studies represent a useful, easily-adaptable approach
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for applying the tools of yeast genetics to the study of conserved mammalian
proteins.
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Table I
SEC13Rp immunogold labeling of transitional area, ER, and Golgi of
pancreatic acinar and insulin cells
No. of gold particles per gm 2 + SEM
Acinar cell Insulin cell
ER (n=10) 0.34 0.18
Transitional 61± 13 110 23
area* (n=10)
(54 ±6 vesicles per pm2; 28% ± 4% (105 ±15 vesicles per pm2; 48% ±7%
of vesicles labeled) of vesicles labeled)
Golgi (n=10) 1±0.7 2±1
n = number of pictures evaluated. Quantitation was performed as described previously
(Orci et al., 1991).
* Including the budding front of the transitional ER, vesicles, and intervening
cytosol.
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Figure 1
Sequence comparison of yeast Secl3p and human SEC13Rp. Identities
are indicated by solid lines, similarities are indicated by dotted lines. The two
amino acids altered during site-directed mutagenesis, corresponding to the
junction site for chimera construction (see Methods), are indicated by carats.
The Secl3p amino acids altered in the three known SEC13 temperature-
sensitive alleles (secl3-1, secl3-4, secl3-5) are underlined (Pryer et al., 1993).
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Figure 2
Effect of human/yeast chimeras in a secl3-1 mutant strain. (a)
Chimeras between human SEC13R and yeast SEC13 can complement a secl3-1
temperature-sensitive allele at the non-permissive temperature (360 C).
SEC13R, SEC13, or chimeric constructs were cloned downstream of a
galactose-inducible promoter in a centromeric vector, transformed into a
secl3-1 mutant, and assayed for growth in the presence of galactose (induced)
or glucose (uninduced) at non-permissive conditions (36 0 C). (b) SEC13Rp
overexpression inhibits the growth of a secl3-1 strain. Assay performed at
240, but otherwise conditions identical to (a).
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Figure 3
Complementation of the secl3-1 secretion defect by both
Secl3p/SEC13Rp and SEC13Rp/Secl3p chimeras. secl3-1 cells carrying the
indicated plasmid were induced for 2 hours in galactose at 240C, shifted to
360 C for one hour, pulse-labeled with Tran3 5S-label for 10 minutes, then
chased by the addition of excess cysteine and methionine. Glass-bead extracts
corresponding to the indicated time points were prepared;
immunoprecipitation was performed using anti-CPY antibodies, and the
precipitates subjected to SDS-PAGE and fluorography. Positions of the pl, p2,
and mature forms of CPY are indicated.
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Figure 4
Complementation of a SEC13-deletion by the Secl3p/SEC13Rp
chimera. 50 ug of protein extract from the indicated yeast strains was
analyzed by western blotting using affinity-purified anti-Secl3p antibody, as
described previously (Pryer et al., 1993). Lane 1, extracts from wild-type yeast;
lane 2, from wild-type yeast expressing the Secl3p/SEC13Rp chimera; lane 3,
from a SEC13-deletion strain expressing the Secl3p/SEC13Rp chimera.
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Figure 5
Specificity of SEC13Rp-induced growth inhibition. Indicated yeast
strains containing a galactose-inducible SEC13Rp construct were incubated at
24°C in the presence of glucose or galactose. Strains used were: DSY174 (wild-
type), DSY223 (secl2), DSY216 (secl3), DSY228 (secl6), DSY232 (secl7), DSY236
(secl8).
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Figure 6
Specificity of antisera to the SEC13Rp protein. 50 ug of the indicated
cell extracts were subjected to Western analysis and probed using the affinity-
purified anti-SEC13Rp antibody. Lane 1, wild-type yeast; lane 2, wild-type
yeast+pGAL-SEC13Rp; lane 3, CHO cells; lane 4, COS cells. The anti-SEC13Rp
antibody recognizes a single predominant species of the predicted molecular
weight, 36 kD.
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Figure 7
Localization of SEC13Rp by immunofluorescence. SEC13Rp appears in
a perinuclear distribution in (a) CHO and (b) COS cells. Immunofluorescence
performed using affinity-purified anti-SEC13Rp antibodies. Magnification:
x700.
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Figure 7
Figure 8
By electron microscope immunolabeling of (a) insulin or (b) acinar rat
pancreatic cells, SEC13Rp is restricted to the transitional area of the ER.
TE=transitional elements of the ER with associated transfer vesicles
(asterisks); the arrow in the inset indicates a labeled bud on a transitional
cisterna; G=Golgi complex; CV = condensing vacuole in the Golgi region.
Note that the dense cytosolic matrix in the transitional area of Fig. 8b is also
labeled in addition to transfer vesicles. See Table 1 for the quantitation of the
immunogold labeling. Magnifications: a) x53,000 (inset x72,000); b) x54,000.
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Figure 8
Figure 9
SEC13Rp labeling of a BFA body. Immunogold particles are present on
the buds (arrows) and vesicles associated with the transitional endoplasmic
reticulum cisterna (TE), but are absent from the dense bands of cytosol
(arrowheads) enriched in coatomer (Orci et al., 1993a), situated between
transitional and non-transitional ER cisternae. BFA-treated insulin cell.
Magnification: x47,600.
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Chapter III
Development of a two-hybrid approach for the identification
of a mammalian homolog of the yeast Secl6p protein
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ABSTRACT
The identification of mammalian homologs of the yeast COPII proteins
Secl3p, Sec23p, and Sarlp suggests that the COPII coat assembly process has
been evolutionarily conserved. Convergent evidence (reviewed in Chapter I)
suggests that in yeast, Secl6p -- an essential protein tightly bound to the
cytoplasmic face of the ER -- may also participate in the assembly of the COPII
coat. This chapter describes the development and implementation of an
approach to clone a mammalian homolog of Secl6p. This strategy was
prompted by the observation that yeast Secl6p can interact with yeast Sec23p
in a two-hybrid system. The cloning project involved three steps: first, a full-
length mammalian Sec23 clone was isolated by hybridization using a partial
Sec23 clone as a probe. Second, since the overexpression of both yeast and
mammalian Sec23 was found to be toxic to cells, a two-hybrid vector was
constructed that would allow for the inducible expression of LexA-fusion
proteins; this allowed the screening a library of activation-domain fusion
proteins capable of interacting with Sec23. Finally, an interaction-trap screen
was performed; 5x10 6 transformants were screened, and 59 positives were
isolated and sequenced. None of the clones analyzed appear to represent a
mammalian Secl6p homolog. Potential explanations for these results are
discussed.
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INTRODUCTION
In eukaryotic cells, the transport of proteins from the endoplasmic
reticulum (ER) to the Golgi is mediated by membrane-bounded vesicles
(Palade, 1975). In vitro analysis of vesicle formation in the yeast S. cerevisiae
has demonstrated the requirement for three cytoplasmic factors: the
Secl3p/Sec31p complex; the Sec23p/Sec24p complex; and the small
molecular-weight GTP-binding protein, Sarlp (Salama et al., 1993; Barlowe et
al., 1994). Convergent evidence also suggests that Secl6p may be involved
intimately in the vesicle formation process. SEC16, an essential gene which
exhibits synthetic lethal interactions with all five COPII genes, encodes a 240
kD protein tightly associated with the cytoplasmic face of the ER (Nakano et
al., 1989; Kaiser and Schekman, 1990; Espenshade et al., 1995; Gimeno et al.,
1995; Salama et al., 1997). Secl6p is required for ER to Golgi transport, and is
found on ER-derived transport vesicles (Espenshade et al., 1995). In addition,
Secl6p has been shown to bind Sec23p (Espenshade et al., 1995). (Since the
work described in this chapter was performed, Secl6p has also been shown to
bind Sec24p and Sec31p [Gimeno et al., 1996; Shaywitz et al., 1997]).
Mammalian homologs of three COPII genes have been characterized.
A mammalian homolog of Sarlp was identified using degenerate PCR (Kuge
et al., 1995). Two clones, Sarla and Sarlb were isolated; these clones are 91%
identical to each other at the amino acid level, and are 61-67% identical to
Sarlp. Immunoelectronmicroscopy using antibodies raised against Sarla (and
also reactive with Sarlb) demonstrated that Sarl is found on the cisternae of
the transitional ER, on the proximal Golgi, and on the intervening vesicles.
Inhibition of the ER to Golgi transport of the marker protein VSV-G in vivo
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and in vitro using a deliberately designed dominant negative Sarl mutant
demonstrated the requirement for Sarl in mammalian ER to Golgi transport.
A mammalian homolog of Secl3p, Secl3Rp, was discovered
serendiptiously (Swaroop et al., 1994). Although SEC13R itself could not
complement the temperature-sensitive secl3-1 mutant, chimeric constructs
representing the N-terminal half of either Secl3p or Sec13Rp, and the C-
terminal half of the other protein, could both complement the secl3-1
secretion defect (Shaywitz et al., 1995). Secl3p was also shown to localize to
the cisternae and vesicles in the region of the transitional ER (Shaywitz et al.,
1995). The localization of Secl3Rp was not affected by BFA treatment, in
contrast to the localization of coatomer subunits; this insensitivity to BFA
was shared by Sec23, and placed these two proteins in a different category
from the proteins of the COPI complex. A recent study of Sec13Rp both
confirmed these localization data and demonstrated that the addition of anti-
Secl3Rp antibodies disrupted the ER to Golgi transport of the marker protein
VSV-G in a semi-intact cell assay, further supporting the notion that the
function of COPII has been evolutionarily conserved (Tang et al., 1997).
At the time the experiments in this chapter were performed, a murine
cDNA sequence strongly homologous to the first 637 amino acids of the yeast
Sec23p protein had been identified (Wadhawa et al., 1993). In addition,
antibody raised against the yeast Sec23p protein appeared to cross-react with a
mammalian Sec23p homolog, which was found to exhibit a subcellular
localization pattern indistinguishable from that of Sarl and Secl3 (Orci et al.,
1991). More recently, two human Sec23 homologs have been identified,
hSec23Ap and hSec23Bp (Paccaud et al., 1996). Antibodies were raised against
the N-terminal region of hSec23A; these antibodies did not react with either
hSec23B or Sec23p. The hSec23A protein complemented a yeast sec23
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temperature sensitive mutant, and was localized, in mammalian cells, to the
transitional ER region. Gel filtration analysis of HepG2 cytosol indicated that
hSec23Ap (like yeast Sec23p) fractionated as a 350 kDa complex.
Immunoprecipitation of hSec23A from clarified cytosol identified a
prominent band with an apparent molecular weight of 110 kD; this is
approximately the molecular weight of yeast Sec24p, the binding partner of
Sec23p. Although a mammalian Sec24p homolog has not as yet been cloned,
a cDNA encoding a protein with significant homolog to Sec24p has been
reported (D38555; KIAA0079 gene product; Nomura et al., 1994).
Two-hybrid analysis using a constitutively-expressed LexA-Secl6p
(amino acids 1645-2194) fusion and a galactose-induced activation domain-
Sec23p fusion demonstrated that these two proteins could interact strongly
(Espenshade et al., 1995). The association between Sec23p and the C-terminal
region of Sec16p has also been observed in vitro (Gimeno et al., 1996).
Attempts to perform the two-hybrid analysis using reciprocal constructs were
unsuccessful; the constitutive overproduction of a LexA-Sec23p fusion was
found to be toxic to the cell.
The strong association of Sec23p and Secl6p in a two-hybrid system,
together with the availability of a mouse cDNA sequence representing a large
region of Sec23, suggested an approach for the identification of a mammalian
Secl6p homolog. First, the partial cDNA would be used to isolate a cDNA
encoding the entire mammalian Sec23 gene. Then, a vector allowing the
expression of Sec23 as an inducible LexA-fusion would be constructed; this
was important because the available two-hybrid libraries were in activation-
domain fusion vectors. Finally, a two-hybrid screen using the inducible
LexA-Sec23 construct would be employed to isolate mammalian Secl6. This
approach was also expected to isolate mammalian Sec24.
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RESULTS
Inspection of the published sequence for a mammalian Sec23 homolog
(Wadhawa et al., 1993) revealed the appearance of a frame-shift; in particular,
the apparent loss of a thymine nucleotide at position 1699 of the mouse
sequence disrupted the strong homology to Sec23p, homology which
continued in a different frame. We elected to use this partial Sec23 sequence
to probe a murine adipocyte library (generously provided by H. Lodish) in an
effort to recover a full-length clone. 800,000 transformants were screened, and
five positive clones were identified, representing two different full-length
inserts. One of these clones was amplified by PCR to insert a convenient 5'
restriction site. This PCR product was then cloned into the galactose-
inducible expression vector pCD43, and complementation of the temperature-
sensitive allele sec23-1 (DSY245 [MATa sec23-1 ura3-52 leu2,3-112 Gal+]) was
assessed over a range of galactose concentrations (Table 1); for comparison, a
galactose-promoted yeast SEC23 expression plasmid (pPE118) was also
evaluated. Although DSY245 cannot grow at 300 C in the presence of vector,
complementation was observed using the full-length mammalian Sec23
clone. This clone was also placed into the pEG202 LexA-fusion vector, to
examine whether the constitutive expression of the full-length mammalian
clone would be toxic. Although transformants grew extremely poorly, the
LexA-Sec23p fusion protein was detectable in extracts prepared from these
transformants by immunoblotting using anti-Sec23p antibody (data not
shown). These results encouraged us to engineer a galactose-inducible LexA-
fusion vector which would permit the regulated expression of the full-length
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Sec23 protein. The construction of this plasmid, designated pGilda, is detailed
in the "Experimental Methods" section of this chapter, below.
To identify human cDNA clones that interact with mammalian Sec23,
a human brain cDNA library (kindly provided by D. Krainc and R. Brent) was
transformed into DSY259, representing the EGY48 strain carrying the
Sec23/pGilda plasmid pDS73 and the indicator plasmid pSH18-34. Since
expression of Sec23 is toxic to cells, we could not identify interacting clones by
a selection process, and were compelled instead to utilize a screen. 5x10 6
transformants were obtained on 120 plates; this represents a density of
approximately 42,000 colonies/plate. Following growth of colonies,
transformants were replica plated to media containing galactose and Xgal.
Blue colonies were identified on these plates after 1-2 days of growth.
Generally, the blue colonies were not well-isolated, and sequential
purification steps were required to obtain a single, positive clone. Yeast in the
vicinity of the blue colony were selected with a toothpick and streaked on a
glucose-containing plate, in effort to isolate single colonies; following growth
of colonies, the plates were replica-plated to plates containing galactose and
Xgal. This process was iterated until pure blue colonies were obtained.
The library plasmid was recovered from the purified yeast by
performing a yeast mini-prep and transforming the DNA into the KC8 strain
of bacteria cells (kindly provided by R. Brent). This strain contains a genetic
lesion complemented by the TRP1 gene on the library plasmid. Thus, by
growing KC8 transformants on plates lacking tryptophan, bacteria containing
the library plasmid were selected. Initially, the library clones were
transformed into the strain RFY206 (Finley and Brent, 1994) and tested by
mating assay against a panel of different LexA-fusion proteins, including
Sed4p, Secl2p, Secl3p, Secl3Rp, four different Secl6p fragments, Isslp (R.
- 89 -
Gimeno, 1996), as well as both yeast and mouse Sec23; the vectors pEG202 and
pGilda were also included as negative controls. Approximately half of the
clones interacting with mammalian Sec23 also interacted with yeast Sec23p;
several clones interacted with Iss1p; other interactions were not detected. The
clones interacting with Sec23p or Isslp did not seem to define a useful
subclass. For example, two clones which interacted with both Iss1p and yeast
Sec23p were identified as S100B, a 91 amino acid calcium binding protein, and
p68, an RNA helicase; these proteins bear no obvious homology to Secl6p or
Sec24p. The balance of the library clones were retransformed into DSY257,
and assayed for interaction with mammalian Sec23.
Of the 240 blue colonies identified, 186 were successfully isolated. Fifty
of these were an identical false-positive (which produced a characteristic
pattern upon the EcoRI/XhoI restriction digest used to determined the size of
the library insert) that would activate transcription of the reporter gene even
in the absence of the Sec23p plasmid; these were not considered further. 66
clones successfully retested by either mating assay or direct transformation
into DSY257; preliminary sequencing was performed on 59 clones.
The results of this analysis are shown in Tables II and III. Of the 59
clones sequenced, 45 corresponded to either known genes or homologs of
known genes, while 14 corresponded to expressed sequence tags (ESTs) in the
database. None of the known genes identified are homologous to either
Sec24p or Secl6p. In particular, although a mammalian homolog of Sec24p is
present in the database (D38555; KIAA0079 gene product; Nomura et al., 1994),
it was not identified in this screen.
The failure to identify overtly the Secl6p gene in the database was not
surprising, since sequences corresponding to Secl6p had never been identified
by BLAST. However, the expectation was that we might either identify a
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novel sequence, corresponding to Secl6p, or else identify candidate EST's that
might not appear to encode a Secl6p fragment as a result of a sequencing
error. By aligning a candidate EST with both the library clone and with
overlapping ESTs, we hoped to generate consensus sequences that might
encode Secl6p. We applied this approach to the eight different ESTs
identified by our screen. In each case, we were able to determine an in-frame
protein sequence corresponding to both our library clone and to a collection of
overlapping ESTs. Each of the protein sequences in Table III represents the
consensus determined from 2-7 aligned sequences. These sequences were
tested against the database (by BLAST) and were individually evaluated
against the Secl6p protein sequence (by ALIGN). Extensive homology was
not detected in any of the comparisons.
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DISCUSSION
This paper describes our attempt to identify a mammalian homolog of
the yeast Secl6p protein by a two-hybrid interaction screen. First, a full-length
mammalian homolog of the yeast Sec23p was isolated by hybridization using
as a probe a partial cDNA clone of the mammalian sequence. Second, a LexA-
fusion vector, pGilda, was constructed to allow for the inducible expression of
toxic proteins such as Sec23. Finally, a two-hybrid screen was performed
using the full-length mammalian clone in the pGilda vector. Fifty-nine
clones were sequenced, but a clone with extensive homology to Secl6p was
not obtained. Potential reasons for this result will be considered
systematically.
1. A mammalian homolog of Secl6p does not exist. This represents the
null hypothesis, and remains in force until disproven. Nevertheless, the
identification of mammalian homologs of Secl3p, Sec23p, Sec24p, and Sarlp
strongly suggests that the process of COPII coat assembly has been
evolutionarily conserved. Given the strong evidence that Secl6p is also
involved in the process of COPII vesicle formation (reviewed in Chapter 1), it
seems likely that a mammalian Secl6p exists.
2. Mammalian Secl6p exists but was not present in this library. This
remains a possibility. Although the level of Secl6p mRNA expression has
not been investigated, such a long transcript may be expressed at a low level,
leading to underrepresentation of the clone in this cDNA library. It should be
noted that the source of this library was human fetal brain, and all of the
COPII proteins which have been examined to date are expressed in this organ
(Shen et al., 1993; Swaroop et al., 1994; Paccaud et al., 1996).
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3. The required region of mammalian Secl6p was not present in this
library. The two-hybrid library used has an average insert size of 1.5 kb.
Sec23p has been shown to interact with the extreme C-terminal region of
Secl6p, and thus, it seemed reasonable to expect this region to be represented
in this library, which was constructed by selection of poly (A)+ RNA followed
by first-strand synthesis primed by oligo-dT. However, it is possible that the
in-frame clone was not present in this library. It should be noted that our
failure to identify mammalian Sec24 in this screen may result from the
requirement for the N-terminal region of Sec24p for Sec23p interaction
(Gimeno et al., 1996); thus, a library clone representing only the C-terminal
region of Sec24p would not be expected to interact with the LexA-Sec23p
protein.
4. The required region of mammalian Secl6p was present but failed to
interact with mouse Sec23p. While it is possible that the murine Sec23p
protein is unable to interact with human Secl6, this seems unlikely. Given
the interactions demonstrated between mammalian Secl3 and yeast Sec31, as
well as the cross-species reactivity seen for antibodies raised against human
Sec23, human Secl3, and yeast Sec23, it seems reasonable to expect the mouse
and human proteins to interact (Paccaud et al., 1996; Shaywitz et al., 1995; Orci
et al., 1991).
5. Mammalian Secl6p was identified in this screen but we are not able
to recognize its identity. This remains a concern. On the one hand, the
mammalian homologs of Secl3p, Sec23p, Sec24p, and Sarlp are
approximately 50% identical to the yeast protein at the amino acid level
(Swaroop et al., 1994; Paccaud et al., 1996; Nomura et al., 1994; Kuge et al.,
1995). Thus, if a similar homolog with mammalian Secl6 exists, we should
easily be able to detect it. However, Secl6p appears to be an extremely
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unusual protein, and in particular, it seems to consist of alternating proline-
rich domains and highly-charged domains (Espenshade et al., 1995). It is
possible that Secl6p could experience significant changes at the amino-acid
level while still retaining its general function; for example, as pointed out by
Gerhart and Kirschner (1997), structural similarity does not necessarily imply
sequence similarity; while the amino-terminal 30 amino acid region of
human and yeast histone H4 are identical between yeast and human, there
are on average 13 differences in this sequence between Tetrahymena and
human; nevertheless, a Tetrahymena protein differing by 25 amino acid
substitutions can functionally replace the corresponding yeast protein in
yeast, emphasizing that conservation of function does not necessarily require
extensive conservation of amino acid sequence.
In summary, it is not possible to determine with precision exactly why
a clone with homology to yeast Secl6p was not isolated in our screen. The
identification of a mammalian Sec31p homolog (suggested by data presented
in Chapter IV), together with the construction of a randomly-primed
mammalian cDNA library, would offer another opportunity for the
identification of a mammalian Secl6p homolog by a two-hybrid approach.
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MATERIALS AND METHODS
General Techniques
Unless otherwise noted, yeast manipulations were performed as described
(Kaiser et al., 1994). DNA manipulations were performed using standard
techniques (Sambrook et al., 1989). PCR was performed using Vent
polymerase according the manufacturer's specifications (NEB, Beverly, MA).
DNA sequencing was performed using the Sequenase kit (United States
Biochemical Corp., Cleveland, OH).
Library screening (identification of full-length murine Sec23 clone)
3T3-L1 cDNA library from differentiated day 8 adipocytes was
generously provided by H. Lodish. Library colonies were screened by
hybridization using the Genius digoxigenin-based system (Behringer),
according to the manufacturer's instructions. Briefly, the partial mouse Sec23
cDNA clone (generously provided by M. Wadhawa) was labeled by random-
primed labeling with digoxigenin-derivitivized-dUTP. Filter lifts (using
Hybond-N nylon membranes [Amersham]) were performed on bacterial
colonies, and DNA was immobilized to the filter by UV crosslinking
following the alkaline lysis of the cells. Hybridization was performed at 650C
using 4 ng/ml of probe. The hybridized probes were immunodetected using
alkaline-phosphatase-conjugated anti-digoxigenin antibody, and the
colorometric substrates NBT (nitroblue tetrazolium) and X-phosphate (5-
bromo-4-chloro-3-indolyl phosphate toluidium salt).
Two-hybrid assay
- 95 -
Potential protein-protein interactions were investigated using the two-
hybrid protein interaction assay and the plasmids pEG202 (constitutive
expression of LexA-fusion), pJG4-5 (galactose-regulated expression of
activation domain-fusion), and pSH18-34 (lacZ reporter) (Gyuris et al., 1993).
Interactions were evaluated in the strain EGY48 (Zervos et al., 1993); positive
interactions were scored as blue colonies on SC medium (pH 7.0) containing
2% galactose and 40 mg/1 X-gal.
Mating assays were performed by transforming the activation-domain
fusion plasmids into EGY48, and transforming the LexA-fusion plasmids
together with the indicator plasmid pSH18-34 into RFY206 (Finley and Brent,
1994). The strains were mated, and lacZ expression was tested by replica
plating diploids on X-gal medium, as above. The following LexA-fusion
plasmids were used in the mating assay: pRH108 (Sed4p); pRH102 (Secl2p);
pRH157 (Sedl3p); pAA35 (Secl3Rp); pPE59 (Secl6p [aal-824]); pPE62p (Secl6
[447-1235]); pPE58 (Secl6p [1645-2194]); pPE74 (Secl6p [447-1737]); pPE249 (Iss1p)
(R. Gimeno, 1996). The KC8 E. coli strain (pyrF, leuB600, trpC, hisB463) was
kindly provided by R. Brent.
pGilda construction
The inducible LexA-fusion vector pGilda (named after the self-
sacrificial Verdi heroine) was constructed as follows: first, the 0.7 kb
BamHI/EcoRI fragment containing the bi-directional GAL1/GALIO
promoters was subcloned from pCD43 (Shaywitz et al., 1995) into the
polylinker of the ARS/CEN, HIS3-marked pRS313 vector (Sikorski and
Heiter, 1989). This construct was then digested with EcoRI and XhoI; these
sites were filled-in using klenow fragment, and the vector religated; this
removed all the restriction sites in the polylinker between EcoR1 and XhoI
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(inclusive). The resulting construct was then digested with BamHI and SacI,
in preparation for the insert constructed as follows.
First, a PCR reaction was performed using pEG202 as the template, and
the following primers: (a) sense: 5'-AACAATCGATATGAAAGCGTTAACG
-3'. (b) antisense: 5'- AACAGAGCTCGGACGGATTACAACA -3'. Primer (a)
inserts a Clal site just prior to the LexA coding region, and primer (b) inserts a
SacI site after the 3' region of the ADH-terminator sequence (basepairs 1745-
1756). The product of this PCR was digested with Clal and Sacl. Next, the
following two oligos were obtained and annealed: (1) 5' - GATCAAGGGTG
-3'; (2) 5'- CGCACCCTT -3'. The 5' end of this adaptor is BamHI-compatible
but corrupts the BamHI site; the 3' end is Clal compatible, but corrupts the
Clal site. A three-way ligation was then performed, using the vector construct
described above (digested with BamHI and Sacl), the PCR fragment (digested
with Clal and Sacl) and the adaptor (compatible with BamHI and ClaI). The
resulting construct has been designated pGilda.
The full-length mammalian Sec23 construct was inserted into pGilda,
to generate pDS73; the LexA-Sec23 fusion protein was specifically detected
after galatose induction, and was not observed in extracts prepared from cells
grown in glucose.
To demonstrate that pGilda could function in two-hybrid analysis, the
gene encoding Sed4p (originally identified as a protein which interacts with
Secl6p) was inserted into this vector, and tested against two different Secl6p
activation-domain fusion constructs, pPE78 and pPE79. Sed4p specifically
interacted with pPE79, and not with either pPE78 or with the vector alone.
This same pattern of interaction was observed when Sed4p was expressed in
pEG202; these data suggested that pGilda could substitute for pEG202 in the
two-hybrid system.
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Two-hybrid cDNA Library
cDNA library from human fetal brain was constructed in the activation
domain fusion plasmid pJG4-5 (Gyuris et al., 1993) by D. Krainc (Mass. General
Hospital), and represents 3.5 x 106 independent transformants. Average
insert size is 1.5 kb.
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Table I: Complementation of sec23-1 by mammalian Sec23
Temperature:
% Galactose:
360C
0.002 0.02 0.2
300C
2 0.002 0.02 0.2
GAL 10-SEC23 (yeast)
GAL 10-Sec23 (mouse)
vector only
- + S M a +
- - - + ++ +
Growth assessed on synthetic complete medium lacking uracil and supplemented with 2% raffinose
and the indicated concentration of galactose.
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Table II: Known Genes Identified in Screen for Mammalian-Sec23 Interactors
Nae # clones Remarks % Proline Accession #
Human heat-shock protein
TFG
Threonyl tRNA synthetase
Pirin
S100B
Proteosome subunit C9
Translation Initiation Factor
p68
p72
Desmoplakin
Rbophorin
DAD-1
snRNP protein B
methylene-THF-reductase
TB2 (FAP locus)
Cyt. C oxidase subunit IV
KIAAO266
hENT1I
signal peptidase subunit
KIAA0069
heat-shock protein
MeCP1
DnaJ homolog
400 aa; present as Trk-fusion in thyroid cancer
nuclear protein
91 aa calcium binding protein
similar to 4AII
RNA helicase; DEAD-box protein; related to p72
DEAD-box protein; related to p68
2677 aa; desmosome associated
631 aa; oligosac.-prot. transferse subunit; ER Ioc.
cell-death protein; subunit of olig.-prot. transferase
cytoplasmic enzyme
gene deleted in familial adenomatous polyposis
homologous to yeast YMLO93w ORF
nucleoside transporter in pm
12 kD; canine gene in database
unknown function
DnaJ homolog; different from above
transcription factor
Secl6p (yeast)
Total number of clones represented: 45- ----------------
4.5
12.2
4.2
7.2
0
1.9
2.7
5.0
6.6
1.9
4.0
3.5
17.2
5.8
4.1
3.6
6.0
4.8
6.9
3.5
5.1
11.3
L08069
Y07968
M63180
Y07867
P02638
T60816
X79538
P17844
U59321
MT/77830
Y00282
D15057
J04564
J04031
M74090
X54802
D87455
U81375
L38852
D31885
004960
Y10746
----------- ------------------------------------------- --
Table III: Composite ESTs Identified in Screen for Mammalian-Sec23 Interactors
AA305793 (4)
VYVKPGNKERGWNDPPQFSYGLQTQAGGPRRSLLTKRVAAPQDGSPRVPASETSPGPPPMG
PPPPSSKAPRSPPVGSGPASGVEPTSFPVESEARLMEDVLRPLEQALEDCRGHTRKQVCDDI
SR
R18915 (3)
AQAAVQGPVGTDFKPLNSTPATTTEPPKPTFPAYTQSTASTTSTTNSTAAKPAASITSKPATLT
TTSATSKLIH
AA043465 (2)
VKNMSSLEISSSCFSLETKLPLSPPLVEDSAFEPSRKDMDEVEEKSKDVINFTAEKLSVDEVSQL
VISPLCGAISLFVGTTRNNFEGEKSH*
AA295402 (2)
PPGAPPFLRPPGMPGLRGPLPRLLPPGPPPGRPPGPPPGPPPGLPPGPPPRGPPPRLPPPAP
PGIPPTRPGMMRPPLVPPLGPAP
AA313126 (1)
RDHRRYFYVNEQSGESQWEFPDGEEEEEESQAQENRDETLAKQTLKDKTGTDSNSTESSETS
TGSLCKESFSGQVSSSSLMPLTPFWTLL
H90481 (1)
NRGSEVIAAGMVVNDWCAFCGLDTTSTELSVVESVFKLNEAQPSTIATSMRDSLIDSLT*
AA315015 (1)
TNNTPMNQSVPRYPNAVGFPSNSGQGLMHQQPIHPSGSLNQMNTQTMHPSQPQGTYASPPP
MS
N49984 (1)
GACTSRPIHPSKAPNYPTEGNHRVEFNVNYTQDLDKVMSGSERN
Composite ESTs assembled from 2-7 overlapping sequences;
Accession number of representative EST is indicated;
Number of library clones corresponding to each composite sequence is indicated;
Total number of clones represented: 15
"*": STOP codon
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Chapter IV
COPII subunit interactions in the assembly of the vesicle coat
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PREFACE
This chapter has been submitted for publication as: David A. Shaywitz,
Peter J. Espenshade, Ruth E. Gimeno, and Chris A. Kaiser (1997): COPII
subunit interactions in the assembly of the vesicle coat.
Peter Espenshade provided the recombinant Sec23p and Sec24p, and
was instrumental in the development of the in vitro binding assays used in
this study. Ruth Gimeno contributed to informative pilot experiments that
first suggested an interaction between Sec24p and Sec31p.
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Summary
In vitro analysis of COPII vesicle formation in the yeast S. cerevisiae
has demonstrated the requirement for three cytosolic factors: Sec31p/Secl3p,
Sec23p/Sec24p, and Sarlp. Convergent evidence suggests that the peripheral
endoplasmic reticulum (ER) membrane protein Secl6p also represents an
important component of the vesicle assembly apparatus: SEC16 interacts
genetically with all five COPII genes; Secl6p binds to Sec23p and Sec24p, is
found on ER-derived transport vesicles, and is required in vitro for the
efficient release of ER-derived vesicle cargo. In this report, we demonstrate
an important functional interaction between Secl6p and Sec31p. First, we
map onto Sec31p binding regions for Secl6p, Sec23p, Sec24p, and Secl3p.
Second, we show that a truncation mutant of Sec31p specifically defective for
Secl6p binding is unable to complement a sec31A mutant and cannot rescue
the secretion defect of a temperature-sensitive sec31 mutant at non-
permissive temperatures. We propose that Secl6p organizes the assembly of
a coat which is stabilized both by the interaction of Sec31p with Sec23p and
Sec24p, as well as by the interaction of all three of these components with
Secl6p.
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Introduction
In eukaryotic cells, proteins which enter the secretory pathway are
synthesized in the endoplasmic reticulum (ER)1, then transported to the
Golgi apparatus via membrane-bounded vesicles (1). Vesicles are formed by
the recruitment and assembly of cytosolic coat components upon the donor
ER membrane (2, 3). Dissection of vesicle formation in the yeast S. cerevisiae
has been facilitated by both the discovery of conditional mutants that are
defective in vesicle formation, and by in vitro reconstitution studies which
have helped define the essential components of the vesicle assembly
machine. In particular, three cytoplasmic factors, collectively termed COPII,
have been shown to be required for vesicle formation: the Sec31p/Secl3p
protein complex, the Sec23p/Sec24p protein complex, and the small GTP-
binding protein Sarlp (4, 5). The addition of these three factors to urea-
washed ER membranes stimulates the formation of coated, fusion-competent
vesicles (4).
While in vitro analysis has been able to define soluble components
required for vesicle assembly, membrane-associated factors have remained
less accessible to biochemical study. Thus, the mechanism of COPII
recruitment and assembly onto the membrane is still unknown. However,
converging genetic and biochemical evidence suggests that Secl6p, an
essential 240 kD multidomain protein, may be involved intimately in this
process. SEC16 is required for transport vesicle formation (6, 7), and exhibits
genetic interactions with all five COPII genes (7-10). Secl6p is tightly
associated with the periphery of the ER, and is also found on ER-derived
transport vesicles (6); furthermore, Secl6p cannot be extracted from
membranes by urea (6). Secl6p has been shown to physically associate with
the COPII subunits Sec23p and Sec24p (6, 11). In addition, membranes
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prepared from secl6 mutant strains exhibit a marked deficit in the release of
vesicle cargo molecules when assayed in vitro (12). Finally, the addition of
antibody against Secl6p to the in vitro budding reaction inhibits the
formation of COPII vesicles. 2
To define more precisely the role of Secl6p, we employed a yeast two-
hybrid interaction screen. We found that the COPII protein Sec31p interacts
with Secl6p, Sec23p, and Sec24p, as well as showing an expected interaction
with Secl3p. These results were confirmed by in vitro binding studies using
full-length Sec31p or truncations of Sec31p, expressed and purified from yeast
extracts as glutathione S-transferase (GST) fusion proteins. The in vivo
significance of the binding of Sec31p to Secl6p was explored using a Sec31p
truncation mutant specifically defective for Secl6p binding. This mutant
could not complement a sec31-null mutant nor rescue the secretion defect of
the temperature-sensitive sec31-2 mutant at non-permissive temperatures.
These findings support the hypothesis that Secl6p functions as a foundation
for the assembly of the COPII coat on the ER membrane.
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Experimental Procedures
General Techniques -- Yeast manipulations were performed by standard
methods (13). Western blotting was performed using the following
antibodies: anti-HA (12CA5; 1/1000; BAbCO); anti-Sec23 (1/250) (14); anti-
Sec24p (1/250) (14); anti-Secl3p (1/250) (15); anti-Sec31p (1/10,000) (5). The
antibodies against Sec23p, Sec24p, and Sec31p were generously provided by R.
Schekman.
Two-hybrid Analysis -- The two-hybrid screen was performed in the indicator
strain L40 (16); subsequent analysis utilized CKY556, representing the strain
EGY40 (17) transformed with the indicator plasmid pSH18-24 (18). The L40
strain was initially transformed with the LexA-Secl6p fusion plasmid, pDS99,
representing the coding sequence for Secl6p amino acids 447-1235 inserted
into the pBTM116 vector (19); this new strain, designed CKY554, was then
transformed with an activation-domain fusion library (generously provided
by M. White) in the pGADGH vector (20). Interactions were tested as
described (18, 21). Sec31p truncation constructs in pGADGH were
subsequently constructed using the cloned SEC31 locus (10), generously
provided by R. Schekman. LexA-fusion constructs were made in pBTM116,
and represent the entire coding sequence of yeast Secl3p (pDS138) (15) and
human Secl3Rp (pDS168) (22, 23), and amino acids 666-926 of Sec24p (pDS272)
(8) and amino acids 447-1043 of Secl6p (pDS116) (6). The entire coding
sequence of yeast Sec23p (14) was inserted into pGilda, to generate pDS72.
pGilda represents a derivative of the pEG202 lexA fusion vector (18) that
retains the multiple cloning sites of pEG202 but which utilizes the GALl
promoter instead of the ADH1 promoter; the vector backbone of pGilda is
from pRS313 (24). To assay quantitatively production of the lacZ reporter
gene, the CKY556 strain was co-transformed with LexA- and activation
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domain-fusion plasmids. Transformants containing a pBTM116-derived
LexA-fusion plasmid were grown to exponential phase in selective medium
containing glucose. Transformants containing a pGilda-derived LexA-fusion
plasmid were grown to exponential phase in selective medium containing
2% raffinose; then galactose was added to 2%, and growth continued for
another 4 hours. At least three independent transformants were assayed for
13-galactosidase activity (13). The mean activity of the transformants is given,
and expressed in Miller units (1000 x OD420/[reaction time x OD600 units
assayed]) (25). All values above background were within 35% of the mean
value.
In vitro Binding Studies -- Recombinant Sec23p and Sec24p were prepared as
previously described (11). Recombinant Secl3p (26) was generously provided
by K. Saxena and E. Neer. The Secl6 protein utilized in these experiment was
prepared as follows: a DNA fragment encoding amino acids 447-1043 of
Secl6p was cloned into the GAL1O-promoted HA expression vector pRH165
(R. Gimeno, unpublished), to generate pDS216. This plasmid was
transformed into the S. cerevisiae strain CKY557 (MATa ura3-52 trpl::hisG
GAL+). Cells were grown to exponential phase in selective medium
containing 2% raffinose, then supplemented with 2% galactose for 4-6 hours
to induce expression of the epitope-tagged protein. These cells were then
washed in LBB-100 (20 mM HEPES-KOH, pH 6.8,80 mM KOAc, 5 mM
MgOAc, 0.02% Triton X-100, 0.1M NaC1) supplemented with protease
inhibitors PMSF (1 mM), leupeptin (0.5 ug/ml), pepstatin (0.7 ug/ml) as well
as EDTA (0.5 mM), then frozen by drops in liquid nitrogen. Frozen cell pellets
were lysed using a mortar and pestle and resuspended in LBB-100. The lysate
was cleared by centriguation at 3,000 x g for 5 min, followed by centrifugation
at 100,000 x g for 40 min.
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DNA regions encoding the entire Sec31p protein, a fragment of Sec31p
lacking the initial 490 amino acids, or a fragment of Sec31p lacking the final 98
amino acids were fused to the 3' end of the glutathione S-transferase (GST)
coding sequence under the control of the GALl promoter in the expression
vector pPE127, a vector identical to pRD56 but in a different reading frame (6).
Clarified cytosolic extracts were prepared as described above, except that the
concentration of NaCl used was 0.6 M; this buffer is referred to as LBB-600.
Glutathione-Sepharose 4B beads (Pharmacia) were incubated with the extracts
for 30 min at 25 0C, then washed three times with LBB-600. Beads prepared in
this fashion were decorated with 2-5 pmol of the fusion protein. For the
binding reactions involving Sec23p, Sec24p, and Secl3p, the decorated beads
were washed twice with binding buffer (25 mM K-Hepes pH 6.8, 0.1% Triton
X-100, 1 mM MgCl2, 0.25 mg/ml BSA). The beads were then resuspended in
45 p.l of salt-supplemented binding buffer, and 5 p1 of the relevant
recombinant protein was then added. Binding of Sec23p (2 pmol) and Sec24p
(1 pmol) was carried out in 50 mM NaC1, while binding of Secl3p (3 pmol)
was carried out in 150 mM NaC1. After incubation for 1 hour at 250 C, the
beads were washed 2-3 times with binding buffer (no additional salt), then
resuspended in extract sample buffer (ESB; ref. 11). For the reactions
involving Secl6p, the beads were washed twice with LBB-100, then incubated
with a yeast cytosolic extract prepared as described. These binding reactions
were carried out in a volume of 100 p.l, and utilized extract containing 126 pg
total protein; NaC1 was added to a final concentration of 0.2 M. Following a
one hour incubation at 25 0C, the beads were washed twice with LBB-100, then
resuspended in ESB. All proteins were subjected to SDS-PAGE followed by
Western blot analysis.
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In vivo Complementation Studies -- Both the SEC31-deletion strain RSY1109
(MAT a ade2-1 ura3-1 leu2-3,112 his3-11,15 trpl-A1 sec31::TRP1 [pNS3111-
SEC31-URA3-CEN]), kindly provided by R. Schekman, and the temperature-
sensitive sec31-2 strain CKY555 (MATa sec31-2 ura3-52 leu2-3,112), kindly
provided by A. Frand, were transformed with pDS321, pDS327, pDS328, or
pRS415 (Stratagene). sec31-2 was identified by A. Frand in a screen for new
mutants temperature-sensitive for ER to Golgi transport; the mutation in
sec31-2 was mapped by marker-rescue of gapped plasmids to a region
corresponding to amino acids 850-1175 (data not shown). pDS321 contains the
full SEC31 genomic locus (6.2 kb BamHI/PstI fragment) inserted into the CEN,
LEU2-marked pRS415 vector. pDS327 and pDS328 both contain a 5.0 kb Sal-
Sall genomic SEC31 fragment which represents a truncation that removes the
coding sequence for the C-terminal 98 amino acids of the protein. pDS327 is a
CEN-based plasmid, derived from pRS415, and pDS328 is a 2p-based plasmid,
derived from pRS425 (27). For the pulse-chase analysis, strains were grown to
exponential phase at permissive temperature (24°C), then shifted to non-
permissive temperature (360 C) for 20 min. Pulse-labeling of cells and
immunoprecipitation of CPY were performed as previously described (23).
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Results and Discussion
Portions of the Secl6p coding sequence were surveyed for regions that
would not by themselves act as transciptional activators when fused to a
DNA-binding domain, and would therefore be suitable for two-hybrid
analysis. pDS99, representing the coding sequence for amino acids 447-1235
of Secl6p inserted into the pBTM116 LexA-fusion vector (19), was one of the
constructs that fulfilled this criterion. This fragment of Secl6p includes the
region known to bind Sec24p (Secl6p amino acids 565-1235), and is distinct
from the region known to bind Sec23p (Secl6p amino acids 1638-2194) (6).
The L40 reporter strain (16) was transformed with both pDS99 and a S.
cerevisiae cDNA library constructed in the activation domain-fusion vector
pGADGH (20). Library plasmids were recovered from strains positive for
expression of both the HIS3 and lacZ reporter genes. A screen of 8x105 S.
cerevisiae cDNA clones yielded seven positives whose activation of lacZ
reporter expression depended upon the presence of the LexA-Secl6p fusion
protein. Six of the positive clones contained overlapping cDNA segments
derived from the 3' region of the SEC31 gene (10). The smallest of these
clones, 2a8, encodes a peptide of 127 amino acids, representing the extreme C-
terminus of the 1273 amino-acid Sec31p molecule.
In an effort to define the functional domains of Sec31p, a series of
Sec31p deletions were constructed in pGADGH and evaluated by two-hybrid
analysis against a series of potential interactors constitutively expressed as
LexA-fusion proteins in the pBTM116 vector (Fig. 1). From this study, the
Secl3p-binding region of Sec31p mapped to the N-terminal third of the
Sec31p protein, a region which contains six WD-40 repeats (28, 29). Constructs
expressing at least the first 490 amino acids of Sec31p, such as pDS131 (Fig. 1),
interacted strongly with Secl3p, while constructs lacking this region failed to
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interact. Since Secl3p itself consists almost entirely of WD-40 repeats (26), the
interaction of Secl3p with the N-terminal region of Sec31p indicates that
these regions of WD-40 repeats associate in a homotypic fashion.
We also examined the interactions of the human Secl3p homolog,
Secl3Rp (22, 23). Secl3Rp can function in yeast (23); in mammalian cells, it is
required for ER to Golgi transport (30), and has been localized to the cisternae
and vesicles in the region of the transitional ER (23, 30). Human Secl3Rp
exhibited a two-hybrid interaction profile identical to that of yeast Sec31p,
interacting specifically with pDS131. These results emphasize the degree of
conservation between yeast and mammalian COPII structures (23, 30-32), and
strongly imply the existence of a mammalian Sec31 protein.
We next asked whether Sec31p could interact with either Sec23p or
Sec24p. Utilizing a domain of Sec24p that does not interact with Sec23p (11),
we determined that Sec24p interacts with the central region of Sec31p
(pDS134), a region that does not interact with either Secl3p or Secl6p. The
evaluation of Sec23p binding to Sec31p required the use of an inducible LexA-
Sec23p fusion protein, since the constitutive overexpression of fusions to
SEC23 fusion was lethal (data not shown). We constructed the vector pGilda,
which allows for the galactose-inducible expression of toxic LexA-Sec23 fusion
proteins, and found that Sec23p interacted specifically with a central, 325-
amino acid region of Sec31p (pDS135). Since the analysis of pGilda-expressed
fusion proteins requires different growth conditions than the analysis of
pBTM116-expressed fusion proteins, the f3-galactosidase activity observed in
strains transformed with the different plasmids, while internally consistent,
are not directly comparable. Both the background t-galactosidase activity and
the B-galactosidase activity in strains containing interacting plasmids were
slightly higher in strains carrying pGilda-derived plasmids.
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To confirm the interactions detected by two-hybrid analysis, we asked
whether Secl6p, Sec23p, Sec24p, and Secl3p could bind to different GST-
Sec31p fusion proteins isolated from yeast. This approach has been used
previously to demonstrate the direct binding of Sec23 and Sec24p to different
regions of Secl6p (11). We evaluated three different GST-fusion proteins:
full-length Sec31p, Sec31p lacking the N-terminal 490 amino acids
(Sec31ANp), and Sec31p lacking the C-terminal 98 amino acids (Sec31ACp).
Sec23p and Sec24p were expressed as GST-fusion proteins in E. coli, purified
by affinity chromotography, then released by thrombin cleavage of the GST
moiety (11). Secl3p (kindly provided by K. Saxena and E. Neer) was purifed as
a hexa-His-fusion protein from E. coli (26). Clarified extracts of yeast
overexpressing the central-domain of Secl6p (amino acids 447-1043) which
had been tagged with a hemagglutinin (HA) eptitope provided the source of
Secl6p for this experiment. This fragment contains the putative Sec31p-
interacting region but is more soluble than the full-length protein.
The results from these binding experiments (Fig. 2) were in complete
agreement with the two-hybrid data. Full-length Sec31p was able to bind
Secl3p, Sec23p, Sec24p, and Secl6p. However, Sec31ANp was specifically
defective for Secl3 binding, while Sec31ACp was specifically defective for
Secl6 binding. Sec23p and Sec24p bound to both of the truncated proteins, but
not to GST alone.
The identification of Sec31ACp, which is specifically defective for
Secl6p binding, allowed us to investigate the in vivo significance of this
interaction (Fig. 3). First, we asked whether sec31-AC could functionally
substitute for wild-type SEC31. A sec31-null strain bearing wild-type SEC31 on
a URA3-marked plasmid was transformed with LEU2-marked plasmids
carrying either SEC31 or sec31-AC. Transformants were grown with selection
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for the LEU2-marked plasmid and then plated on medium containing 5-
fluoroorotic acid (5-FOA). Only yeast capable of growing in the absence of the
URA3-marked plasmid would be expected to grow under these conditions.
The strains carrying the plasmid with sec31-AC did not produce segregants
that could grow on 5-FOA (Fig. 3A), showing that the truncated protein lacks
an essential function of Sec31p.
As a control for protein expression levels, the wild-type yeast strain
CKY8 (6) was transformed with either a CEN-plasmid carrying sec31-AC or
with vector alone. Extracts from both strains were examined by
immunoblotting using anti-Sec31p antibody (Fig. 3D) (5). Sec31ACp was
present in equivalent amounts to the endogenous Sec31p, indicating
significant production of the truncated protein.
To address more directly the role of the C-terminal region of Sec31p in
secretion, we utilized a temperature-sensitive allele of SEC31, designated
sec31-2, which was isolated in a screen for new mutants defective for ER to
Golgi transport. By testing whether Sec31ACp could rescue the secretion
defect of sec31-2 observed at non-permissive temperatures, the ability of
Sec31ACp to fulfill the function of Sec31p in ER to Golgi transport could be
assessed. The sec31-2 mutant was transformed with plasmids encoding either
Sec31p or Sec31ACp; growth of the transformants at the non-permissive
temperature of 360 C was then evaluated. While mutants transformed with
the SEC31 plasmid grew at 360 C, mutants transformed with the sec31-AC
plasmid remained temperature-sensitive for growth (Fig. 3B); these results
were observed in mutants transformed with either a CEN-based or a 2M-based
sec31-AC plasmid. The kinetics of ER to Golgi transport of the marker cargo
protein carboxypeptidase Y (CPY) was followed by pulse-chase analysis of the
transformants at 360 C. The sec31-AC plasmid did not rescue the CPY transport
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defect (Fig. 3D). Because the binding studies showed that the only apparent
defect of Sec31ACp is in binding to Secl6p, the transport defect exhibited by the
truncated allele of SEC31 argues that the binding of Sec31p to Secl6p is
required for ER to Golgi transport. However, we cannot eliminate the
possibility that the C-terminal region of Sec31p performs an additional
function which has not yet been defined that is necessary for secretion.
Reconstitution studies in both yeast and mammalian cells demonstrate
that vesicle coat formation can be stimulated by the addition of a defined set
of cytosolic factors to washed donor membranes (4, 5, 33). For transport
between Golgi cisternae in mammalian cells, these factors are the small GTP-
binding protein ARF and the coatomer protein complex, consisting of seven
subunits which coassemble in the cytosol and bind en bloc to the donor
membrane (34). For transport between yeast ER and Golgi, two different
cytosolic protein complexes in addition to the small GTP-binding protein
Sarlp are needed to form the COPII vesicle coat (3, 14,15). The interaction that
we have detected between purified components of the Sec31p/Secl3p protein
complex and the Sec23p/Sec24p protein complex suggested that these two
complexes may pre-assemble in the cytosol. To examine this possibility, we
expressed a GST-Sec31p fusion protein in yeast and asked whether Sec23p or
Sec24p could could be found associated with this fusion protein in a cytosolic
extract prepared under conditions of the in vitro transport assay (4, 15). We
were unable to detect either of these proteins in the bound fraction. This
observation is consistent with our measurements of the stability of the
interactions between isolated proteins: binding of GST-Sec31p to recombinant
Sec23p and Sec24p was detected at 50 mM NaC1, but was not seen at 150 mM
NaC1, a salt concentration equivalent to that used for the in vitro assay (data
not shown). Under the same conditions, binding of GST-Sec31p to Secl3p or
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Secl6p was stable (Fig. 2). Consequently, it is likely that the physiological
association between the two COPII complexes requires the context of the ER
membrane.
Conditional mutants of SEC16 exhibit synthetic lethal interactions with
conditional mutants of SEC13, SEC23 (7), SAR1 (8), SEC31 (10), and SEC243.
Given that SEC16 interacts genetically with all five COPII genes and encodes a
peripheral ER membrane protein that is present on ER-derived transport
vesicles, required for vesicle formation, and binds directly to Sec23p, Sec24p,
and Sec31p, we propose that Secl6p functions as a foundation for the
construction of the COPII coat from soluble protein complexes (Fig. 4). The
demonstration that Sec31p binds directly to both Sec23p and Sec24p suggests
that the assembling COPII subunits are stabilized not only by interactions with
Secl6p but also by interactions with each other. Progress in understanding
the stepwise mechanism of COPII recruitment and assembly may come from
more precise definition of how the individual protein-protein interactions
between COPII subunits that we describe here are controlled.
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1. Abbreviations: ER, endoplasmic reticulum; GST, glutathione S-transferase;
HA, hemagglutinin. PAGE, polyacrylamide gel electrophoresis. CPY,
carboxypeptidase Y; 5-FOA, 5-fluoroorotic acid
2. P. Espenshade and C. Kaiser, unpublished results.
3. A. Frand, R. Gimeno, and C. Kaiser, unpublished results.
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Figure 1.
Dissection of Sec31p binding domains through the use of two-hybrid analysis.
The clone 2a8, a cDNA expressed in the activation-domain fusion pGADGH
and encoding the C-terminal 127 amino acids of Sec31p, was identified in a
two-hybrid screen for proteins that interact with the central region of Secl6p
(amino acids 447-1235), expressed from the LexA-Secl6p fusion plasmid
pBTM116. To define more precisely the domain structure of Sec31p, a series
of Sec31p truncations were constructed in pGADGH. The peptide fragments
represented by the activation-domain fusions are: pDS131 (1-490); pDS134
(570-1175); pDS135 (850-1175). These plasmids were evaluated against a series
of LexA-fusions to SEC13, SEC24 (coding sequence for amino acids 666-926),
SEC23, and SEC16 (coding sequence for amino acids 447-1043) for expression of
a lacZ reporter. Analysis of Sec23p interactions required the inducible
expression of the LexA-Sec23p fusion protein with GALl-regulated vector
pGilda. The regions of Sec31p that contain WD-40 repeats and proline-rich
sequences are indicated in the diagram.
- 127-
pBTM116
Proline-rich
Secl3 Secl3R
(human) Sec24 Secl6
48
<1
<1
<1
<1
27
<1
<1
<1
462
272
31
13-galactosidase activity (Miller Units)
Fpire1
Sec31
WD-40
pGilda
Sec23
pDS131
pDS134
pDS135
2a8
217
<1
<1
<1
F-H
H
M
Figure 2.
Binding of COPII subunits to Sec31p in vitro. (A) GST-fusion proteins
representing full-length Sec31 (1273 amino acids), a N-terminal truncation
lacking the first 490 amino acids (Sec31AN), a C-terminal truncation lacking
the final 98 amino acids (Sec31AC), or GST alone were immobilized on
gluthathione agarose and incubated with recombinant Sec23p, Sec24p, Secl3p,
or clarified extract from yeast overexpressing the central domain of Secl6p
(amino acids 447-1043) tagged with a hemagglutinin (HA) epitope. The bound
fraction was resolved by SDS-PAGE, and proteins were detected by Western
blotting. A sample representing the total amount of protein added to the
reaction was also included for each protein analyzed; ratio of total to bound
loaded is 1:1 for the three recombinant proteins, and 1:10 for the Secl6p
extract. The recombinant Secl3p migrates slightly slower than endogenous
Secl3p, and the doublet in the Secl3p lanes indicates that both proteins co-
purify with Sec31p and Sec31ACp. (B) The affinity-purified GST-Sec31 fusion
proteins used in the binding reactions were separated by SDS-PAGE on a 10%
gel and stained with Coomassie brilliant blue.
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Secl6p-binding region of Sec31p is essential and required for ER to Golgi
transport. Plasmids expressing either Sec31p (CEN- plasmid) or Sec31pAC
(both CEN- and 2p-plasmids) were transformed along with a vector-only
control into either RSY1109, which carries a chromosomal deletion of the
entire coding sequence of SEC31 covered by SEC31 on a ULIRA3-containing
plasmid, or CKY555, which carries the temperature-sensitive allele sec31-2.
(A) RSY1109 transformants were plated on medium containing 0.1% 5-
fluoroorotic acid (5-FOA) to assay for complentation of the null allele. (B)
CKY555 transformants were plated at both permissive (24°C) and non-
permissive (360 C) temperatures, to assay complementation of the sec31-2
allele. (C) The transport of the vacuolar protein carboxypeptidase Y (CPY) in
the CKY555 transformants at non-permissive temperatures was examined by
pulse-chase analysis. Exit of CPY from the ER is observed only in the strain
expressing the full-length wild-type Sec31p protein. Positions of the pl (ER),
p2 (Golgi), and mature (vacuole) forms of CPY are indicated, as is the time in
minutes of chase. (D) Expression of Sec31ACp. Extracts were prepared from
the wild-type yeast strain CKY8 (6) transformed with either sec31-AC on a
CEN-plasmid (lane 1) or vector only (lane 2); samples were resolved by SDS-
PAGE and transfered to nitrocellulose. Proteins were detected by Western
blotting using anti-Sec31p antibodies.
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Figure 4.
Proposed role of Secl6p in the organization of the COPII coat. Formation of
COPII vesicles in vitro requires the presence of three cytosolic components:
the Sec31p/Secl3p complex, the Sec23p/Sec24p complex, and the GTP-binding
protein Sarlp. Secl6p, which is tightly associated with the cytosolic face of the
ER membrane, is proposed to organize the assembly of the COPII coat, binding
directly to Sec31p, Sec23p (6), and Sec24p (11). The interaction of Sec31p with
Sec23p and Sec24p is also expected to contribute to the assembly and stability
of the COPH coat. No attempt at correct stoichiometry has been made. Direct
interaction of Sarlp with Secl6p has not been demonstrated.
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The work presented in this dissertation represents an attempt to
further our understanding of the proteins responsible for the formation of
COPII coated vesicles. In yeast, each of the COPII proteins has been shown to
be required for ER to Golgi transport. Homologs of three COPII proteins --
Secl3p, Sec23p, and Sarlp - have been discovered in mammalian cells; each
of these homologs has been localized to the cisternae and vesicles in the
region of the transitional ER. Mammalian Secl3 and Sarl have been shown
to be required for ER to Golgi transport (mammalian Sec23 was not
examined). Collectively, these data emphasize the extent to which the process
of COPII-mediated protein transport has been evolutionarily conserved.
Although the individual steps leading to the formation of COPII
vesicles remain incompletely understood, we are beginning to define many of
the interactions involved in this process. One possible mechanism leading to
the formation of the COPII coat is described below.
In this model, the first step in vesicle formation is the recruitment of
the small molecular weight GTP-binding protein, Sarlp. This is presumably
mediated by Secl2p, an ER membrane protein known to function as a
nucleotide exchange factor for Sarlp. Although Secl2p itself is not found in
transport vesicles, it has recently been found to associate with Secl6p (P.
Espenshade, unpublished results). Given the relatively weak nucleotide
exchange activity which has been demonstrated for Secl2p, the existence of a
co-factor which would enhance this activity seems a reasonable possiblility,
and Secl6p would be well-situated to perform this function.
Although the Secl3p/Sec31p and Sec23p/Sec24p complexes are usually
considered to be cytosolic factors, their intracellular location has not been
definitively established. For example, Sec23p was initially thought to be a
membrane-associated protein, and its release into the cytosolic fraction was
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only accomplished by both vigorous lysis and specific pH conditions (Hicke et
al., 1989). In our hands, only a very small amount of either of these
complexes is present in the cytosolic fraction of cells lysed vigorously in the
presence of 50 mM NaCl; increasing the salt concentration to 150 mM
increases the recovery of these proteins. Thus, while it is common to speak of
the recruitment of the Secl3p/Sec31p and Sec23p/Sec24p proteins from the
cytosol (e.g. Schekman and Orci, 1996), these factors may exist as loosely-
associated peripheral ER membrane proteins, possibly bound to either
transmembrane cargo proteins or cargo adaptors (vide infra). Thus, the role
of Sarlp may be to initiate the lateral recruitment of the COPII sub-complexes
(along with their bound cargo) to Secl6p. Alternatively, the COPII molecules
may exist loosely associated with Secl6p itself; perhaps Sarlp alters the
conformation of pre-bound complex molecules to a more stable
configuration.
A central feature of our model of COPII vesicle formation is the
proposed function of Secl6p as a foundation for COPII coat assembly.
Evidence in support of this model include:
* SEC16 interacts genetically with SEC12, SEC13, SEC31, SEC23, SEC24,
and SAR1;
* SEC16 is essential, and is required for ER to Golgi transport;
* Secl6p is tightly associated with the ER membrane, and is found on
ER-derived transport vesicles;
* Secl6p binds Sec31p, Sec23p, Sec24p, and Secl3p (see Appendix II);
* secl6 mutant membranes are impaired for COPII vesicle formation in
vitro;
* antibodies to Secl6p inhibit vesicle formation in vitro (P.
Espenshade, unpublsihed results).
-138-
Assembly of the COPII coat might be facilitated by homotypic
interactions between Secl6p molecules (P. Espenshade, unpublished results);
the molecules of the COPII sub-complexes might also serve a cross-linking
function: for example, Sec23p bound to one Secl6p molecule might be
associated with Sec24p bound to a different Secl6p molecule. Similarly,
Sec31p bound to one Secl6p molecule could interact with either Sec23p or
Sec24p associated with a different Secl6p molecule.
The role of the COPII coat proteins in cargo selection remains an
important question. It seems reasonable to envision that the COPII coat
might participate in the selection of vesicle cargo, and function as a large
"sorting receptor." In the case of transmembrane cargo, this might be
accomplished by direct interactions with the COPII coat; the two-hybrid
interaction between Secl6p and Chslp (Appendix I) might represent one
example of this type of association. Soluble cargo would require association
with an adapter molecule, a transmembrane protein that might interact both
with the COPII coat on the cytosolic face of the ER as well as with specific
cargo molecules within the ER lumen. Emp24p/Bst2p might function in this
capacity, although the direct binding of cargo to this protein has yet to be
demonstrated. The possibility that a transmembrane cargo protein might
function as an adaptor for soluble cargo should also be considered.
The evolutionary conservation of COPII function affords the
opportunity to study a fundamental biological process in several different
systems. For example, different, highly-specialized cell-types might employ
slightly different COPII proteins; the COPII coat used by a cell devoted to the
secretion of insulin might well differ slightly from the coat used by a cell
devoted to the secretion of vasopressin. Alternatively, the coats might be
identical, but the (proposed) adaptor molecules different. The determination
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of the core components involved in this process allows us to examine how
this basic theme has been developed and modified in different biological
systems; in turn, this knowledge provides a us with a more nuanced
understanding of the essential process under investigation.
Our knowledge of ER to Golgi transport has advanced considerably in
the seventeen years since the initial sec screen was performed. The
combination of genetic and biochemical approaches have enabled us to define
and purify the proteins required for the in vitro reconstitution of vesicle
formation at the ER. However, many unresolved questions remain,
including:
* Are there additional proteins (either soluble or membrane-
associated) reguired for vesicle formation in vivo? Does Iss20p (Appendix I)
represent an example of such a protein?
* What is the step-wise sequence of events leading to the formation of
the vesicle coat?
* What is the role played by membrane lipids in both vesicle formation
and cargo selection?
* What is the structure of membrane-associated Secl6p?
* What is the role (if any) of Secl6p in the selection of the site of vesicle
budding? If Secl6p is involved in this process, how is its recruitment
regulated?
* What is the role (if any) of the COPII coat in either initiating
membrane deformation or in the scission of the completed vesicle?
Having defined the critical components of COPII vesicle formation
machinery, we are now challenged to understand how these components
collaborate, and how their function is regulated physiologically.
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PREFACE
Appendix I and Appendix II extend upon the experiments presented in
Chapter IV; the reagent descriptions and reference lists appearing in these
sections are intended to complement the information included in the
chapter.
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Appendix I
Preliminary characterization of the
Secl6p-interacting protein Iss20p
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OVERVIEW
Three two-hybrid screens were performed in effort to identify proteins
that would interact with Secl6p. One of these screens, described in Chapter
IV, identified Sec31p as a candidate interactor. Three additional genes were
identified by these screens. CHS1 and OLE1 were identified in screens for
proteins that interact with the C-terminal region of Secl6p (amino acids 1645-
2194); ORF YPPO49c (also yp9499.07c, and here designated ISS20 [Interacts with
Sec Sixteen]) was identified in a screen for proteins that would interact with
the central region of Secl6p (amino acids 447-1235). Both Chslp and Olelp
have been described previously, and both are associated with the organelles of
the secretory pathway. Chslp encodes a chitin synthase, and has three
transmembrane domains; the protein has been localized to both the plasma
membrane and to intracellular membrane-bound particles known as
chitosomes (Leal-Morales et al., 1994). Chslp thus represents an example of a
cargo protein which transits through the secretory pathway, and might
interact with Secl6p during packaging into transport vesicles at the ER.
Olelp, a fatty acid desaturase, has seven potential transmembrane domains,
and resides in the ER (Stukey et al., 1990). As such, it might contribute to the
anchoring of Secl6p to the ER membrane. Although we have not further
pursued the study of these proteins, the role of Olelp and particularly Chslp
in the recruitment of the COPII coat bears further investigation.
ISS20 represents a novel gene, predicted to encode a 1178 amino acid
protein that contains a prominent coiled-coil domain (Fig. 1). Regions within
this domain of Iss20p exhibit 17-25% identity to regions within the extensive
coiled-coil domain of the general fusion factor Usolp; this homology thus
seems to reflect a shared structural motif, and need not imply a shared
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function. The balance of this section describes preliminary attempts to
determine the whether ISS20 is involved in ER to Golgi transport.
PRELIMINARY CHARACTERIZATION OF ISS20
ISS20 was isolated in the same screen which identified Sec31p as an
interactor with the central region of Secl6p (Chapter IV). The region of
Secl6p which binds to Iss20p was subsequently mapped to a 165-amino acid
region of Secl6p (amino acids 660-824). This region by itself does not exhibit
interactions with Sec23, Sec24p, or Sec31p. The ISS20 clone isolated represents
the C-terminal 812 amino acids of the 1178 amino acid full-length protein
identified as the open reading frame YPRO49c in the database. The partial
ISS20 clone was used as a probe to identify by hybridization and then isolate
the complete genomic locus from a library in pCT3 (Thompson, 1993). Two
different pCT3 clones containing the entire ISS20 ORF were identified,
pDS158 (containg 1.5 kb upstream sequence and 6.4 kb downstream sequence)
and pDS161 (4.3 kb upstream sequence and 1.0 kb downstream) (see Fig. 1).
This determination was based on the sequence analysis of the insert ends, and
comparison with the yeast genome database.
To determine if ISS20 is essential, the genomic locus was disrupted by
one-step gene replacement (Rothstein, 1991). Two independent
transformation constructs were made. In the first approach (outlined in Fig.
2), fragments representing the 5' and 3' ends of the ISS20 gene were isolated
by restriction digest and cloned into the integrating vector pRS306 in the
appropriate orientation, to generate pDS178. The wild-type yeast strains CKY8
and CKY10 were mated, and the resulting diploid strain (MATa/a ura3-
52/ura3-52 leu2,3-112/leu2-3,112) was transformed with pDS178 that had been
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linearized by digestion with NotI. Transformants were selected on media
lacking uracil; two transformants were then sporulated; 16 of 20 tetrads
exhibited a 2:2 (live:dead) segregation pattern, 3 tetrads had one live spore,
and 1 had no live spores. The dead spores in tetrads exhibiting a 2:2 pattern
seemed to double 3-4 times before arresting, as 7-15 microcolonies were
observed under the microscope. These data were most consistent with the
disruption of an essential gene.
To investigate whether ISS20 was required for ER to Golgi transport,
we wanted to generate a strain carrying a chromosomal deletion of ISS20
covered by a plasmid expressing Iss20p from a galactose-regulated promoter.
By examing the transport of the marker cargo protein CPY following the
transfer of cells from medium containing galactose to medium containing
glucose, the involvement of Iss20p in ER to Golgi transport might be
determined. To conduct this experiment, we first needed to construct a ISS20-
deletion heterozygote that was both Gal+ and which retained the uracil
auxotrophy. To accomplish this, we mated strains CKY263 and CKY264 to
generate the diploid strain DSY388 (MAT a/a ura3-52/ura3-52 leu2,3-
112/leu2,3-112 Gal+/Gal+). Next, we designed an integration fragment that
utilized the 5' and 3' regions of ISS20 (generated by PCR) and a hisG-URA3-
hisG fragment as the selectable marker (see Fig. 3). Growth of strains
containing this fragment (obtained by digesting pDS285 with KpnI and NotI)
on 5-FOA results in recombination between the hisG regions, and loss of the
URA3 gene, thus regenerating the original uracil auxotrophy. Transformants
of DSY388 were initially plated on media lacking uracil. Sporulation of two
randomly-chosen transformants resulted in a 2:2 (live:dead) segregation
pattern. One of these transformants (DSY388) was then grown in the presence
of 5-FOA. Segregants were then selected, and found to be Ura-, as expected.
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One of these segregants (DSY389) was then spoulated, and again, a 2:2
segregation pattern was observed.
To verify that disruption of the ISS20 gene was responsible for the
observed lethality, pDS161 was transformed into DSY389. Surprisingly,
sporulation of the segregants revealed a 2:2 pattern, in 10/10 tetrads
examined. These results are discussed below.
We also attempted to demonstrate a role for Iss20p in secretion using
an approach recently developed by the laboratory of K. Struhl (Moqtaderi et
al., 1996). In this "double-shutoff" system (Fig. 4), the gene to be studied is
expressed as a fusion with ubiquitin and the hemagglutin (HA) epitope, and
is placed under the control of a Rox1p-repressible promoter (Zitomer and
Lowry, 1992). Integration of this fusion constructed is directed to the locus of
the gene to be studied, thus disrupting it, and ensuring that the only source of
the gene is the integrated fusion construct. A strain is utilized in which both
UBR1 and ROX1 are placed under the control of a promoter regulated by
Acelp (Furst and Hamer, 1989). Addition of copper to the growth medium
results in the rapid expression of both UBR1 and ROX1, and the subsquent
repression of the target gene as well the ubiquitin-mediated degradation of its
protein product (Johnson et al., 1992). As a result of the addition of copper,
the gene under examination is transcriptionally repressed and the protein
product is degraded. In tests of this system transcription factors have been
shown to be reduced to only 1% of their steady-state level in two hours. After
Iss20p depletion, pulse-chase analysis of CPY transport could then be used to
evaluate the effect on secretion.
Generation of the integration plasmid required a 5' region of ISS20 that
containing a unique site which could be used to linearize the integration
plasmid. A 120 bp 5' region of ISS20 was amplifed by PCR; this fragment,
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which contained a centrally-located PstI, was inserted into pZM168, to
generate pDS240. This plasmid was linearized with PstI, and transformed
into ZMY60 (equivalent to DSY373). The transformation efficiency appeared
to be quite low, possibly reflecting the small size of the regions (approximately
60 bp each) required for recombination. However, several transformants
were obtained. All the transformants were able to grow on selective media
containing copper, suggesting that if the fusion construct was functioning as
designed, then the fusion protein was not essential for cell viability.
In an attempt to increase the transformation efficiency, another fusion
plasmid (pDS264) was constructed that utilized a longer fragment of ISS20,
also generated by PCR. Again, the transformation efficiency of ZMY60
appeared quite low, but several transformants were obtained. All the
transformants tested were again able to grow on selective media containing
copper. To test for the expression of the fusion protein, extracts were prepared
from either ZMY60 transformants or from the orginal ZMY60 strain. Proteins
were separated by SDS-PAGE, and analyzed by immunoblotting using anti-
HA antibodies. A protein of the predicted size was present in the
transformant extracts, but not the control ZMY60 extracts, suggesting that the
construct had integrated in the expected location. The effect of copper
induction on the expression of the fusion protein has not yet been
investigated.
The simplest explanation for these results is that ISS20 is not an
essential gene, and that the disruption of ISS20 is lethal because it disrupts an
important regulatory region of a neighboring gene. Presumably, this
neighboring gene is not entirely represented on the pCT3 clone used to assess
complementation. The best candidate gene is ORF YPRO48W (also
yp9499.06w). The 3' end of this ORF (predicted to encode a NADPH-
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cytochrome p450 reductase) is less than 100 bp away from the 3' end of the
Iss20p coding sequence, and thus, it is possible that disruption of the ISS20
locus might also corrupt regulatory elements required for proper expression
of the YPRO48W gene. Since this gene is approximately 2 kb in length, it
would not be encompassed by the pDS161 clone, explaining why this clone
did not complement the ISS20 disruption. If this explanation is correct, then
transformation with pDS158, which contains 6.4 kb of sequence 3' of the ISS20
gene, should rescue the lethality. Southern blot analysis could also be
performed to confirm disruption of the ISS20 gene.
In summary, while the interaction of Iss20p with Secl6p raises the
possibility that Iss20p is involved in ER to Golgi transport, as yet we have not
been able to obtain confirmatory evidence to support this hypothesis, and
further studies will be required to clarify the role of this novel protein.
MATERIALS AND METHODS: construct generation
pDS178. pDS161 was digested with KpnI and Bam to liberate a 5.6 kb fragment
spanning the ISS20 locus. This fragment was inserted into pKS(+) to generate
pDS167. pDS167 was then digested with PstI, followed by reaction with
klenow fragment to generate a blunt end. The DNA was then digested with
SpeI to generate a 640 bp fragment representing the 121 bp of the ISS20 coding
sequence. This fragment was cloned into pKS(+) that had been digested with
Clal, reacted with klenow to blunt the end, then digested with Spel; the
resulting plasmid, designated pDS177, was then digested with NotI and XhoI,
and the insert (representing the extreme 5' region of ISS20) recovered.
pDS167 was digested with SacI and NotI to obtain a fragment representing the
extreme 3' region of ISS20. A three-part ligation was then performed using
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these two inserts and a fragment obtained by digesting pRS306 with SacI and
XhoI. The resulting plasmid, designated pDS178, was linearized with NotI
prior to transformation.
pDS285. pDS226 represents the 5.6 kb BamHI/KpnI ISS20 fragment cloned
into the pRS316 vector. To generate fragments reprsenting the 5' and 3'
regions of ISS20, PCR reactions were performed using pDS226 as the template,
and the following primers: Reaction I: sense primer: Stratagene T3 sequence;
anti-sense primer: 5'-AAAGATCTTTAATCAGCGTCTGCCATGATG-3'.
Reaction II: sense primer: 5'-AAAGATCTGGAGTTTGAACAGTGCTAAAC-
3'; antisense primer: Stratagene T7 sequence. Reaction I fragment was
digested with KpnI/BglII, reaction II fragment was digested with Bglll/NotI,
and pKS(+) was digested with KpnI/NotI; a three-part ligation was then
performed to generate pDS284. A 3.8 kb BamHI/BglII fragment containing
the hisG-URA3-hisG sequence was recovered by digestion of pNKY51 (Alani
et al., 1987), generously provided by N. Kleckner. This fragment was inserted
into pDS284 that had been digested with BglII, to generate pDS285. The 6 kb
KpnI/NotI insert was used for transformation.
pDS240. pDS161 was used as a template for a PCR reaction using the
following primers: sense: 5'-AAGAATTCCATGGCAGACGCTGATG-3';
antisense: 5'-AAGCGGCCGCAAATCAACATTCGTAG-3'. This PCR fragment
was digested with R1/NotI, and inserted into pZM168 (digested with the same
enzymes). The resulting plasmid was then digested with KpnI/NotI, and the
recovered 1kb fragment was inserted into pRS404, to generate pDS240. This
plasmid was linearized with PstI prior to transformation.
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pDS264. pDS167 was used as a template for a two PCR reactions using the
following primers: reaction I, sense: 5'-
AAGAATTCCATGGCAGACGCTGATG-3'; antisense: 5'-
GGTCTAGAGTAAAAGACCTATTA-3'; reaction II, sense: 5'-
GGTCTAGATGATTTTTACGTTTAC-3'; antisense: 5'-
GGCGGCCGGATATATGACTATTC-3'. These PCR fragments were digested,
respectively, with EcoRI/XbaI and XbaI/EagI, and inserted into pZM168
(digested with EcoR1 and EagI), to generate pDS263. This plasmid was then
digested with KpnI/SacI, and the 1.3 kb recovered fragment was inserted into
pRS306. This plasmid was linearized with XbaI prior to transformation.
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Figure 1
(A) Map of ISS20 (YPRO49C) genomic locus. Arrows indicate
orientation of ORFs. YPRO48W represents a neighboring ORF encoding a
protein with homology to the NADPH-cytochrome p450 reductase. MAK3
encodes an N-acetyltransferase required for the propogation of the L-A
doubled-stranded RNA virus (Tercero and Wickner, 1992). pDS158 and
pDS161 represent pCT3 clones (Thompson et al., 1993) containing the
indicated genomic regions.
(B) Diagram of Iss20p, indicating the location of the coiled-coil domain
(Paircoil sequence analysis program, Berger et al., 1995). The region of Iss20p
encoded by the library clone isolated in the two-hybrid screen for Secl6p
(amino acids 447-1235)-interactors is also shown.
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Figure 2
Gene disruption of ISS20 using pDS178. See text for details.
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Figure 3
Gene disruption of ISS20 using fragment excised from pDS285; see text
for details.
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Figure 4
Outline of double-shutoff system. The system consists of two parts: (1)
a parent strain (ZMY60) containing copper-inducible alleles of ROX1 and
ULIBR1; (2) a short 5' region of ISS20 fused in frame with a ubiquitin-arginine-
lacI-HA ("URLF") cassette, and regulated by the ANB1 promoter; this fusion
construct is inserted into an integrating vector. The resulting "disruption
plasmid" -- in this case, either pDS240 or pDS264 -- is linearized at a site
within the ISS20 fragment, and integrated by homolgous recombination as
shown. (Note that full-length HA-tagged Iss20p will only be produced if the
disruption plasmid integrates in the proper location.) When the strain
containing the correctly-integrated plasmid is induced with copper,
transcription of the fusion product is repressed by Rox1p, while Ubrlp
mediates the degradation of the residual URLF-Iss20p protein. See text for
details.
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Appendix II
Two-hybrid interactions of Secl6p with Sec31p, Sec24p, and Secl3p
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SUMMARY
Sec31p and Sec24p have both been shown to bind to the central region
of Secl6p (amino acids 447-1293). In an attempt to map the binding sites more
precisely, the interaction of Sec31p, Sec24p, and Secl3p with different regions
of Secl6p was evaluated by two-hybrid analysis. We report the identification
of regions of Secl6p that interact specifically with each of the three proteins
investigated.
RESULTS AND DISCUSSION
Sec24p and Sec31p were both previously shown to bind the central
region of Secl6p (amino acids 447-1235). In an effort to determine more
precisely where Sec24p and Sec31p bound Secl6p, protein fragments
representing different regions within the central domain of Secl6p were
expressed as LexA-fusions. These constructs were transformed into CKY556
and evaluated by two-hybrid analysis against the following proteins,
represented as activation domain-fusions: Sec24p (C-terminal region, amino
acids 666-926); Sec31p (C-terminal region, amino acids 1147-1273); and Secl3p.
The results of this analysis (Fig. 1) suggest that specific regions within
the central domain of Secl6p interact with Sec31p, Sec24p, and Secl3p.
Interpretation of these data is complicated both by the high background
associated with the pDS293-transformants, and by the weak association
observed between pDS143 and the Sec24p constructs (though this association
was consistently found to be above background).
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These data represent the first evidence that Secl3p directly associates
with Secl6p, and lend additional support to our hypothesis that Secl6p serves
as a foundation for the assembly of the COPII coat (Fig. 2).
MATERIALS AND METHODS: plasmids used in two-hybrid analysis
LexA-fusion plasmids (vector: pBTM116):
pDS293 (Secl6p, amino acids 447-700).
pDS143 (Secl6p, amino acids 661-824).
pDS144 (Secl6p, amino acids 877-1235).
Activation domain-fusion plasmids (vector: pGADGH):
2a8 (Sec31p, amino acids 1147-1273).
pDS271 (Sec24p, amino acids 666-926).
pDS141 (Secl3p).
pDS102 (vector only).
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Figure 1
Dissection of Secl6p binding domains through the use of two-hybrid
analysis. To define more precisely the binding domains within the central
region of Secl6p (amino acids 447-1235), a series of Secl6p truncations were
constructed in the LexA-fusion vector pBTM116: pDS293 (Secl6p amino acids
447-700); pDS143 (amino acids 661-824); pDS144 (amino acids 877-1235). These
plasmids were evaluated against a series of activation domain-fusions to
SEC31 (coding sequence for amino acids 1147-1273), SEC24 (coding sequence
for amino acids 666-926), and SEC13 for expression of a lacZ reporter. Regions
of the central domain of Secl6p that contain charge-rich and proline-rich
sequences are indicated in the diagram, as is the region containing the known
secl 6 ts mutations.
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Figure 2
Two models of COPII assembly upon Secl6p, reflecting all interactions
detected by two-hybrid analysis. See text for details.
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